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Abstract 
 
Flavohemoglobins are oxygen binding proteins composed of a heme-containing globin 
domain fused with a ferredoxin reductase-like FAD- and NAD-binding domain. Genes 
codifing for these proteins have been identified in a wide variety of bacteria and eukaryotic 
microorganisms, although their physiological role is still uncertain. A possible function for 
flavohemoglobins has been proposed in the framework of the response to nitrosative stress as 
they are able to catalize the oxidation of free NO to nitrate in the presence of oxygen and 
NADH.  
The aim of this work is to determine the structure of Escherichia coli flavohemoglobin 
(HMP) and to investigate novel possible enzymatic functions for the protein. We have found 
that HMP is able to bind reversibly a number of unsaturated and cyclopropanated 
phospholipids and fatty acids as well as liposomes obtained from E. coli total lipid extract. 
Along the same line, HMP is shown to be an efficient alkyl hydroperoxide reductase, thus 
suggesting that the protein is involved in a specific lipid hydroperoxide repair mechanism 
induced by oxidative/nitrosative stress. 
 1.  INTRODUCTION 
 
The common perception of hemoglobins and myoglobins as proteins tailored for the 
transport and storage of oxygen is not adequate to describe the functional properties of 
globins within all living organisms. In fact, the discovery of globin genes among prokaryotic 
and eukaryotic microorganisms including bacteria, yeasts, algae, protozoa and fungi rules out 
the possibility that globin genes were originally designed for oxygen transport or storage. At 
present, the number of these “hemoglobin-like” proteins is steadily increasing as novel 
genomes from microorganisms are sequenced and annotated. Such a massive input of newly 
discovered hemoglobins is revealing an unsuspected and amazingly wide distribution of 
globin genes within living organisms that are very distant from the phylogenetic point of 
view. In this framework, within the evolutionary time frame, oxygen transport appears as an 
emergent function, customized from much older physiological roles, whose nature is under 
active investigation by the scientific community (Wu et al. 2003, Poole et al. 2000).  
 
1.1 The globin superfamily 
  Globins can be classified in the framework of a superfamily on the basis of the 
conservation of the so-called “globin fold”, a structural motif made of eight alpha helices 
(form A to H). Alpha helices are arranged in a globular structure that embeds the heme in a 
central hydrophobic cavity between helices E and F. As a general rule, globins classification 
must necessarily be based on structural alignments rather than on simple sequence alignments. 
This concept was developed by Lesk et al., already in 1987. Upon examination of about 200 
globin sequences (from vertebrates, invertebrates and a few plants) and a dozen of 
tridimensional structures, they pointed out that very few residues are strictly conserved in 
globins and that the sequence identity between phylogenetically distant globins can be as low 
as 15%.  
All globins are structurally related to vertebrate hemoglobins and myoglobins in that, 
besides the conservation of the typical globin fold, the heme is always covalently linked to the 
polypeptide chain through a proximal histidine residue (HisF8) and a Phe residue (PheCD1) 
appears to be necessary to keep the heme in the correct orientation within the pocket. 
However, apart from HisF8 and PheCD1, a wide array of different aminoacidic residues can 
be accommodated within the heme pocket. In fact, several topological positions that are 
important for the interaction of aminoacid side chains with the iron bound ligand in the distal 
pocket are not conserved among globins. A typical example concerns the topological position 
E7, that in vertebrate hemoglobins and myoglobins is a histidine residue but is changed to 
glutamine in several species. When leaving the world of vertebrate globins to explore the 
structural features of the (randomly distributed) invertebrate globins, the variability of the 
aminoacid substitutions within the distal heme site becomes impressive, such that in some 
nematode hemoglobins none of the distal heme pocket residues is conserved with respect to 
the aminoacids present in higher vertebrate. Finally, climbing the phylogenetic tree up to 
unicellular microorganisms, an explosion of different novel (or, more appropriately ancient) 
globins is observed such that an expansion of the parameters defining the globin family is 
required. In fact, in many microorganisms, including bacteria, yeasts, algae, protozoa and 
fungi the classical globin fold is not fully conserved. Microbial globins includes more than a 
globin family, namely truncated hemoglobins, globin coupled sensors and flavohemoglobins. 
Globin coupled sensors (GCS) include a number of chimeric proteins in which the globin 
domain is fused with a transducer domain involved in aerotaxis or gene expression regulation 
(Freitas et al. 2003). Interstingly, the globin domain of these GCS and in particular the heme 
containing active site is structurally analogous to the globin domain of flavohemoglobins 
(Hou et al. 2001). Thus, flavohemoglobins can be considered as a distinct class of chimeric 
proteins in which the non-globin module is a typical flavodoxin reductase-like domain 
(Andrews et al. 1992). On the other side, truncated hemoglobins (trHbs) share little sequence 
 and structure similarity to oxygen sensor domains in that they lack two of the eight helices 
typical of the globin fold and exhibit a wide array of possible aminoacid substitutions within 
the active site (Wittenberg et al. 2001). Thus, trHbs have been assigned to a distinct group 
within the globin superfamily. As a consequence of this multibranched phylogenetic tree, the 
creation of a globin superfamily that includes these novel microbial globins is currently under  
development.        
Most recently, the presence of ancestral globin genes in thermophilic Archaea has also 
been demonstrated, thus corroborating the idea that hemoglobins were designed for roles 
different than oxygen transport in the primordial atmosphere (Wu et al. 2003). The Archaea 
proteins have been considered as ancestors of bacterial globins and accordingly have been 
termed protoglobins (Freitas et al. 2004). Evolution of protoglobin genes has been suggested 
to give rise to different globin subfamilies, including flavohemoglobins, whose physiological 
functions diverged.  
 
1.2 The flavohemoglobin family 
Flavohemoglobins are widespread within prokaryotes and eukaryotes although their 
distribution among different species is apparently hazardous and does not follow a discernable 
pattern. So far, Enterobacteriacee and soil microorganisms all have a flavohemoglobin gene, 
Actinobacteriacee and Streptomyces often possess more than a flavohemoglobin and some 
unicellular eukaryotes (Candida albicans) share up to five different genes codifying for 
flavohemoglobins. The steadily growing input from novel genomes is providing a continuous 
challenge for the phylogenetic classification of flavohemoglobins such that yearly upgrade of 
genomic databases includes at least a handful of novel proteins from different organisms. At 
present, flavohemoglobins have not been identified as yet in strict anaerobes and in Archaea 
although, as mentioned in the previous paragraph, the presence of single chain protoglobins 
displaying a significant structural similarity with the flavohemoglobins heme domain have 
been reported recently (Freitas et al. 2004).  
The flavohemoglobin family is formed by a very homogeneous group of proteins that 
share highly conserved active sites in both the heme and flavin binding domains. The 
conserved aminoacids within the heme domain include the residues lining the heme pocket on 
both the proximal and distal site thus indicating that there must be a strong regio- and 
stereochemical requirement for ligand binding and/or for gaseous ligand diffusion. In parallel, 
also the aminoacid residues responsible for flavin binding are strictly conserved and conform 
to the typical architecture of flavodoxin-reductase proteins indicating clearly that the flavin 
moiety serves as an electron transfer module from the NADH to the heme. Sequence 
alignments carried out on separate domains rapidly diverge towards the globin family on one 
side and on flavodoxin or ferredoxin reductase family on the other thus suggesting that 
flavohemoglobins have originated from the fusion of a protoglobin ancestor and a flavin 
binding domain. Updated sequence alignments and phylogenetic trees have been worked out 
in the framework of the present thesis and will be presented and discussed in detail.     
   
1.3 Escherichia coli flavohemoglobin 
The flavohemoglobin from Escherichia coli (HMP) has been the first discovered 
protein of the flavohemoglobin family. Since its identification in 1991, HMP has been object 
of a large number of investigations aimed to unveil its physiological role and its structural 
properties.  
HMP is encoded by a 1191 bp DNA fragment located at 2683.90 kb in the E. coli 
chromosome. Its promoter overlaps that of the adjacent gly A gene which is however 
transcribed in the opposite direction. HMP expression is regulated by the FeS protein FNR 
(fumarate and nitrate reduction), which predominantly functions as a positive transcription 
factor, though its role of repressor is also important. FNR recognizes a consensus sequence 
and binds the DNA in response to exogenous signals such as anoxia, redox state, oxidative 
 and nitrosative stress (Korner et al. 2003). Inspection of the DNA upstream of the hmp reveals 
two potential FNR-binding sites (Poole et al. 1996). One site, 5’-TTGAG-N4-ATCAA-3’, is 
centered 34 bp upstream of the hmp translation start codon and closely resembles the 
consensus sequence, 5’-TTGAT-N4-ATCAA-3’; its position is consistent with an inhibiting 
function. A second potential FNR site, 5’-TTGAC-N4-AGGAA-3’ is centered 222 bp 
upstream of the hmp translation start codon, but has a weaker resemblance to the consensus 
FNR-binding sequence. 
HMP expression seems to be also regulated by Met R. One gene  activated by Met R 
with homocysteine as cofactor is gly A, whose promoter overlaps that of hmp. It has been 
demonstrated that in E. coli elevated homocysteine levels decrease hmp expression 
(Membrillo-Hernandez et al. 1998). Furthermore, induction of HMP expression was observed 
in cells entering the stationary growth phase. This induction is mediated by the stationary  
phase-specific sigma subunit (σS) of RNA polymerase (Membrillo–Hernandez et al. 1997). 
HMP was first identified in the course of an attempt to discover genes that encode E. 
coli dihydropteridine reductase (DHPR) activities (Vasudevan et al 1991). The authors found 
a chromosomal DNA fragment that directed the synthesis of two soluble polypeptides of 44 
and 46 kDa. The  larger protein was serine hydroxymethyltransferase, encoded by the gly A 
gene, while the smaller was the product of an unassigned gene closely linked to gly A, and 
divergently transcribed. Soluble extracts of E. coli cells that overproduced the 44 kDa protein 
had elevated DHPR activity. Their visible absorption spectra were indicative of a b-type 
hemoprotein and the sequence of the N-terminal 139 residues of the protein were highly 
homologue to Vitreoscilla hemoglobin, the first bacterial hemoglobin to be discovered.  
In 1992, Andrews and co-workers detected three soluble ferrisiderophore reductases in 
E. coli. One of these was purified and identified as the hemoglobin-like protein (HMP). So 
far, the protein previously isolated as a dihydropteridine reductase was then shown to have 
ferrisiderophore reductase activity (Andrews et al. 1992).  
Later on, based on the impetus provided by the active and successful research on the 
biological effects of nitric oxide (NO) and on multiple experimental evidences of an interplay 
between the NO catabolism and hemoglobin chemistry, it was proposed that HMP might act 
in connection with a novel NO pathway in bacteria. In particular, HMP was suggested to play 
a role in the framework of bacterial resistance to nitrosative stress. So far, HMP expression 
has been demonstrated to respond to the presence of nitric oxide in the culture medium 
(Hausladen et al. 1998, Membrillo-Hernandez et al. 1999), and an explicit mechanism has 
been proposed that involves FNR mediated NO induced expression of the flavohemoglobin 
(Poole et al. 1996, Cruz-Ramos et al. 2002, Corker et al. 2003). HMP has been shown to be 
able to scavenge and reduce NO to N2O under anaerobic conditions (Kim SO et al. 1999). In 
contrast to (or together with) the anaerobic NO reductase activity, HMP has also been shown 
to be able to catalyze the oxidation of free NO to nitrate (nitric-oxide dioxygenase activity) 
both in vivo and in vitro in the presence of oxygen and NADH (Gardner et al. 1998). 
Alternatively, an NO denitrosylase function has been proposed in which, at low oxygen 
tensions, HMP turns over in the ferric state with the intermediacy of an iron-bound nitroxyl 
anion that is subsequently transformed into nitrate in the presence of oxygen (Hausladen et al. 
2001). It remains to be established which of these diverse enzymatic activities might 
correspond to a physiologically relevant process. Nevertheless, more recently, other non-heme 
iron proteins in E. coli have been identified that are able to perform NO dioxygenase or 
reductase activities with a much higher efficiency than flavohemoglobin (Gardner et al. 2003, 
Gomes et al. 2002, da Costa et al. 2003) thus tuning down the hypothesys of a direct 
participation of HMP to NO scavenging. The reaction of flavohemoglobin with NO might 
thus appear simply as a manifestation of the rich and complex chemistry between NO and 
heme iron rather than a physiologically relevant phenomenon.  
 
 
 1.4 HMP and oxidative stress response 
Reactive oxygen species (ROS) are known to be responsible of oxidative damage to 
macromolecules in vivo and in vitro. Treatments of cells with redox-active drugs may cause 
lethal damages that involve oxidation of DNA, RNA, membranes and proteins. As a result of 
the exposure to exogenous ROS generating agents, all aerobic living cells are able to generate 
O2- (or H2O2) when molecular oxygen oxides redox enzymes that are designed to transfer 
electrons to other substrates. 
E. coli, as well as most bacteria, respond to oxidative stress by invoking two distinct 
stress response: the superoxide stimulon and the peroxide stimulon, each containing a set of 
about 40 proteins, under the control of OxyR and SoxRS systems. These proteins include 
catalase-peroxidases (katG and katE), superoxide dismutases (sodA and sodB), glutathione 
synthetase (gshAB), glutathione reductase (gor), endonucleases (nfo, nth), porin (ompF) and 
alkyl hydroperoxide reductase (ahpC). The signal for the OxyR regulon induction appears to 
involve the action of H2O2 directly, whereas the induction of SoxRS modulon occurs in two 
steps. An unidentified intracellular signal of oxidative stress changes the conformation of 
SoxR protein into a transcriptional activator of the soxS gene. The SoxS protein then activates 
the transcription of genes belonging to the modulone (Amabile-Cuevas et al. 1991). SoxRS 
system is activated by redox cycling agents (such as paraquat) that generate intracellular 
superoxide (Farr et al. 1991), and by nitric oxide (Nunoshiba et al. 1992). 
As previously reporter, HMP itself is responsive to nitric oxide, but unlike other NO-
induced genes, the induction of HMP is SoxRS independent. Besides, it has been observed 
that HMP is able to generate superoxide radicals and H2O2 (Membrillo-Hernandez et al. 
1996), acting as an amplifier of superoxide stress and leading to the full expression of SoxRS 
stress response.  
A novel set of functional hypotheses pertaining the involvement of HMP in the 
oxidative stress response has been inferred on the basis of structural studies based on X-ray 
diffraction and resonance Raman spectroscopic investigations. In particular, X-ray 
crystallographic studies carried out on similar proteins, namely Alcaligenes euthrophus 
flavohemoglobin (FHP) and the single chain hemoglobin from Vitreoscilla sp (VHB), pointed 
out that the structural geometry of the active site was strongly reminiscent of that of typical 
peroxidases. The 3D structure of VHB and FHP revealed that the proximal heme pocket is 
characterized by a network of hydrogen-bonding interactions that comprises the Nε atom 
(hydrogen-bonding donor) of the proximal histidine, thus conferring an anionic character to 
the imidazole ring (Tarricone et al. 1997, Ermler et al. 1995). The spectroscopic signature of 
the peroxidase-like character of the active site has been provided by resonance Raman 
measurements on the fully reduced, deoxygenated HMP derivative whose spectrum displays a 
very high iron histidine-stretching frequency, in line with the values observed for typical 
peroxidases (Mukai et al. 2001). Subsequently, infrared absorption measurements conducted 
on the cyanide-bound ferric species confirmed the structural analogies between HMP and 
peroxidases highlighting the strong electron donation to the iron-bound ligand (Bonamore et 
al. 2001). These features can be taken as a central structural motif that allows to distinguish 
between genuine hemoglobins, in which the integrity of the ligand in the trans position needs 
to be preserved, and peroxidases, in which electron donation to the trans oxygen ligand up to 
the cleavage of the O-O bond is at the core of the catalytic activity (electron push effect). 
Moreover, the presence of both a glutamine and a tyrosine (Tyr B10) in the distal site of the 
heme pocket suggested that these two residues might well play the same role as the His-Gln 
couple in typical peroxidases.  
These last observations, indicating that HMP may be endowed with peroxidase and/or 
monooxygenase activities, represent the starting point of the present work.  
 
 
 
 1.5 Biotechnological applications of bacterial hemoglobins 
It is of interest that, despite the poorly understood physiological role, the 
biotechnological applications of bacterial hemoglobins have exploded in a myriad of 
industrial processes, in particular in bio-oxidative transformations (Minas et al. 1998, Nasr et 
al. 2001, Urgun-Demirtas et al. 2003, Lin et al. 2003, Khang et al. 2003). The presence of 
recombinant bacterial hemoglobins within the host cell has been shown to promote the growth 
rate and increase cell density of the transformed cells even under oxygen limiting conditions, 
to improve the bio-oxidation product yield, to alleviate oxidative and nitrosative stress during 
the stationary phase and ameliorate both heterologous enzymes expression and their catalytic 
capabilities (Bollinger et al. 2001, Frey et al. 2000, Frey et al. 2002, Kim YK et al 2004). 
Thus improved E. coli vectors expressing bacterial hemoglobin-like proteins are routinely 
used in several bioreactors and large fermentors. The observed beneficial effects of bacterial 
hemoglobins have been initially attributed to a facilitated oxygen delivery to oxidizing 
enzymes, including the terminal oxidases of the host cell (Park et al. 2002, Kallio et al. 1994). 
This hypothesis has been challenged on the basis of the extremely slow rate of oxygen release 
characteristic of bacterial hemoglobins, a phenomenon that rules out facilitated oxygen 
diffusion (Giangiacomo et al. 2000).  
 
1.6 Aim of the work 
The aim of this work is to determine the structure of Escherichia coli flavohemoglobin 
and to investigate novel possible enzymatic function for the protein. HMP is thought to be 
involved in the response of bacterial cell to the potentially harmful role of free nitric oxide in 
giving rise to the nitrosative stress. Nevertheless, although the nitric oxide dioxigenase stands 
as the major functional hypothesis for HMP, a number of experimental observations carried 
out on highly similar proteins  have revealed different possible scenarios for bacterial 
hemoglobins’ functions. In particular, the structural resemblance of the heme environment of 
flavohemoglobins with classical peroxidases suggested the participation of these proteins to 
some sort of peroxidase-like activity towards some unknown substrate. Recently, different 
kind of bacterial hemoglobins have been demonstrated to interact with membrane 
phospholipids both in vivo and in vitro. In fact, Alcaligenes eutrophus favoemoglobin has 
been crystallized with a tightly phospholipids within the heme pocket and Vitreoscilla 
hemoglobin, as well as Mycobactrerium tuberculosis truncated hemoglobin, has been reported 
to be preferentially located in contact with the bacterial inner membrane in vivo and to be 
capable of reversible binding to liposomes in vitro.  
In this framework, the interaction of HMP with heme ligands and with membrane 
lipids will be investigated and possible enzymatic activity involving membrane phospholipids 
will be screened. 
 2.  MATERIALS AND METHODS 
 
2.1 MOLECULAR BIOLOGY METHODS 
 
2.1.1 Cloning and expression of HMP 
The hmp gene encoding for the Escherichia coli flavohemoglobin was amplified from 
the bacterial genomic DNA. A Polymerase Chain Reaction has been performed using the 
Vent Polymerase (Biolabs), the forward primer 5’-GGAAGACCATATGCTTGACGCTC-3’ 
which contains a Nde I restriction site and the reverse primer 5’-
CGGGTCAATCGGATCCGTACCGG-3’ 70 base pairs downstream the stop codon, which is 
cut by BamH I.  
A PTC-150 Mini Cycler Hot Bonnet apparatus (MJ Research, inc.) was used to carry 
out the gene amplification. The PCR mix had the following composition: 100 ng genomic 
DNA, 50 pmol forward primer, 50 pmol reverse primer, 250 µM dNTPs, 1.6 units Vent 
Ploymerase, 1X Vent buffer and 50 µl deionized water. The amplification steps, 1 minute at 
95°C, 1 minute at 65 °C, 1 minute and 30 seconds at 72 °C, were repeated 30 times. The PCR 
product was loaded onto an agarose gel, analyzed by electrophoresis and extracted from the 
agarose using a QIAquick Gel Extraction Kit (QIAGEN). 
hmp and the expression vector pET 11-a (Novagen) were cut with both Nde I and 
BamH I, purified and ligated. The ligation reaction was performed using Ready-To-Go T4 
DNA ligase (Amersham Pharmacia biotech).  
Escherichia coli k12 BL21 (DE3) made competent to be transformed through CaCl2 
treatment were transformed with the ligation mix and the clones containing the plasmid pET 
11-hmp were selected by their ability to grow in plates in the presence of ampicillin. 
One of these clones was growth in LB liquid medium supplemented with 100 mg/l of 
ampicillin for about 16 hours. Afterwards 60 mg/l of δ-aminolevulinic acid (ALA) were 
added and after another 30 minutes the HMP expression was induced by adding 1mM IPTG. 
4 hours later the cells were recovered by centrifugation. 
 
2.1.2 Cloning and expression of the mutant 
The GluH23-Val mutant of HMP was obtained by making use of site-directed 
mutagenesis by whole plasmid synthesis (WHOPS). This method is based on the capability of 
certain DNA polymerase to be used for the synthesis of entire plasmid, using a pair of 
complementary primers, which introduce the point mutation. In our case the mutant sense 
primer is 5’-GGCTAATGTATTTATCAATCGCGtGGCGGAAATCTATAACGAAAAGC-
3’ and the mutant antisense primer is 5’-
CGTTTTCGTTATAGATTTCCGCCaCGCGATTGATAAATACATTAGCC-3’. 
pET11-hmp plasmid used as WHOPS template was isolated from a Dam methylation 
competent strain (DH5α). The PCR mix was as following: 100 ng plasmid DNA, 0.5 µM 
mutant sense primer,  0.5 µM mutant antisense primer, 250 µM dNTPs, 1X polymerase 
buffer, 2.5 units Pfu turbo polymerase (Fermentas), 50 µl deionized water. The PCR cycle 
was 45 seconds at 95 °C, 1 minute at 68 °C, 4 minutes at 70 °C for 16 times. 10 units of the 
restriction enzyme Dpn I were directly added to the PCR reaction, so that the methylated 
template which did not carry the mutation could be digested. This mix was then used to 
transform BL21 (DE3) strains. The introduction of the mutation was confirmed by DNA 
sequencing. 
To express the mutant protein we used the same protocol described for the wild type 
HMP. 
 
2.1.3 Cloning and expression of the heme domain 
The HMP heme domain was cloned in a the pET-11a plasmid. pET 11-hmp vector 
was chosen as template for PCR amplification. Vent DNA polymerase was used with the 
 primer pairs forward 5’-GAAGACCATATGCTTGACGCTC-3’ and reverse 5’-
GCGAGTAGGATCCTAACGACGACGACGGCTGGCGTTTTCG-3’.  The reverse 
oligonucleotide was drown adding 4 arginine codons, 1 stop codon and a restriction site for 
Bam HI at the end of the H helix of the heme domain. The 470 bp product was isolated from 
an agarose gel and digested with both Nde I and Bam HI. The product was then purified and 
ligated in the pET-11a plasmid, cut with the same restriction enzymes. The ligated product 
was transformed into Escherichia coli BL21 (DE3) strain and the clones containing the 
plasmid were selected by their ability to grow in the presence of ampicillin. A recombinant 
plasmid screening was then performed using a control PCR and confirmed by DNA 
sequencing. 
HMP heme domain has been expressed as reported previously for the full length 
protein. 
 
 
2.2 PREPARATIVE BIOCHEMISTRY METHODS 
 
2.2.1 HMP extraction and purification 
E. coli flavohemoglobin, cloned and overexpressed in E. coli, was purified by means 
of a three-steps chromatographic procedure that avoids amoniun sulfate precipitation and 
yields ≥ 5 mg of pure protein per liter of culture. The E. coli crude extract was loaded onto a 
DEAE 52 column equilibrated with 10 mM Tris-HCl buffer at pH 8 containing 0.1 mM 
EDTA, 1 mM dithiothreitol and 1 mM potassium cyanide. The flavohemoglobin was eluted 
with an NaCl gradient at 0.18 M salt concentration. The fraction with flavohemoglobin higher 
than 50 %, as judged by SDS-PAGE, were pooled, dialyzed against 5 mM phosphate buffer at 
pH 7 and loaded onto a microceramic hydroxyl-apatite (Bio-Rad, Hercules, CA, USA) 
column equilibrated with the same buffer. A 5-50 mM phosphate gradient (pH 7.0) was 
applied and the protein eluted at a buffer concentration of 15 mM. The fractions containing 
more than 90 % flavohemoglobin were directly loaded onto a DEAE-Toyo Pearl (Toso Haas) 
column equilibrated with 15 mM phosphate buffer and eluted with an NaCl gradient (0-0.25 
M). The protein obtained was 98 % pure on SDS-PAGE and was fully saturated with flavin 
cofactor as judged from the ratio (0.27) between the absorption peak of the heme cyanide 
complex (419 nm) and the oxidized flavin peak (480 nm). 
The flavohemoglobin concentration was determined spectrophotometrically using a 
molar absorptivity of 156000 M-1 cm-1 at 419 nm for the ferric cyanide derivative. 
 
2.2.2 Extraction and purification of the HMP GluH23-Val mutant 
HMP mutant overexpressed in E. coli is not fully saturated with the heme cofactor. For 
this reason the protein has been reconstituted with hemin, dialyzed against phosphate buffer 
20 mM pH 7 and then loaded onto a G-25 gel filtration column. Afterwards the mutant was 
purified as previously described for the native protein.  
 
2.2.3 Extraction and purification of the heme domain 
The HMP heme domain was purified by using the first two chromatographic steps 
used in the whole HMP purification, i.e. a DEAE 52 column and  a microceramic hydroxyl-
apatite column. An easier purification was feasible owing to the four C-terminal arginine 
residues, that increased the isoelectric point of the heme domain with respect to the other E. 
coli proteins. 
 
2.2.4 Phospholipids extraction and manipulation 
Total E. coli lipid extracts (TLE) were prepared according to Bligh and Dyer (1959). 
Briefly, 250 mg of E. coli pellets obtained after sonication and centrifugation of whole cells 
were washed with deionized water, dried under vacuum at -5 °C and dissolved in 5 ml of a 
 methanol/chloroform (2:1 v/v) solution. The solution was vortexed at room temperature and 
stored at 4 °C for 24 hours. Thereafter, the sample was centrifuged at 6000 rpm, the 
supernatant was kept at 4 °C and the pellet was subjected to a new extraction procedure as 
before. Then, 5 ml of chloroform and 5 ml of water were added to the chloroform methanol 
supernatants, the chloroform phase was separated, dried under nitrogen gas at 4 °C and stored 
at -20 °C. The effective removal of protein components from the lipid extracts was checked 
by IR spectroscopy (absence of the 1650 cm-1 amide band).  
Fatty acids methyl esters (FAME) from E. coli total lipids were obtained with a single-
step (extraction-transesterification) method (T. Lewis et al., 2000). 50 mg of freeze-dried cells 
were put into a screw-top test tube, suspended in 3 ml of the transesterification mix 
(methanol:hydrochloric acid:chloroform (10:1:1 v/v/v)), and paced at 90 °C. After about an 
hour, the tube was removed from heat. 1 ml of water was then added and the FAME extracted 
(hexane:chloroform, 4:1 v/v, 3x2 ml). For gas chromathographic (GC) analysis, the sample 
was dried and suspended in absolute hexane. 
 
2.2.5 Crystallization procedures 
Crystallization experiments were carried out at 25 °C using the sitting drop vapor 
diffusion method.  A volume of 4 µl of protein sample (22 mg/ml) in water was mixed with 
an equal amount of the reservoir solution containing 0.1 M sodium acetate buffer, pH 5.1-5.3,  
21-26 % PEG 3350 and 0.2 M NaCl. Crystals grew in one week to about 0.05 mm × 0.05 mm  
× 0.1 mm.  
Data were collected as 0.5 oscillation frames on the ELETTRA  beamline at Basovizza 
(Trieste) at a wavelength of 1.0 Å and at 100 K using  26 % PEG 200 as cryoprotectant. Data 
analysis, performed with DENZO (Otwinowski et al. 1997) indicates that the crystals are 
hexagonal P622 with cell dimensions a=b=164.86 Å, c=53.46 Å, α=β=90°, γ=120°. Heavy 
atoms derivatives were generated by soaking crystals in reservoir solution plus 5mM 
Hg(CH3COO)2 (36 h), or 5mM K2PtCl4 (48 h).  
 
 
2.3 ANALYTICAL BIOCHEMISTRY METHODS  
 
2.3.1 High Pressure Liquid Chromatography 
HPLC has been used to screen the activity of HMP towards cumyl hydroperoxide. A 5 
ml solution containing 5 µM HMP, 5 mM NADH, and 2.2 mM cumyl hydroperoxide in 0.1 
M phosphate buffer was equilibrated under nitrogen for 1 hour at 25 °C. A protein-free blank 
was also prepared under the same condition. The reaction was quenched by the addition of 5 
ml of ethyl acetate and 2 mM benzyl alcohol was added as internal standard. The organic 
phase was recovered and split in two phases. The first sample was dried under vacuum and 
resuspended in methanol for HPLC analysis. The methanol solutions (blank and sample) were 
injected onto an Agilent 1100 Series HPLC system equipped with a Supelcosil LC-18DB (25 
cm × 2 m) reverse phase HPLC column. The products were eluted with 30% v/v 
methanol/water solution at a flow rate of 0.5 ml/min and monitored at 256 nm.  
 
2.3.2 Gas Chromatography/Mass Spectrometry 
The reaction products obtained from the cumyl hydroperoxide in the presence of HMP 
were also analysed by GC/MS. In fact, since the organic phase of HMP-cumyl hydroperoxide 
reaction becomes poor in benzyl alcohol (internal standard) after drying under vacuum, part 
of it was directly used for GC analysis. GC analysis was carry out using a Varian CP-3800 
gas chromatographic apparatus equipped with a CP-Sil 5 CB column (30 cm × 0.25 mm) in 
the following conditions: 10 min at 40 °C, 7°C/min up to 250 °C, 10 min at 250 °C. 
 
 
 2.3.3 Electrospray Ionization Spectrometry 
For ESI mass spectrometry measurements, linoleic acid hydroperoxide or its reaction 
products were extracted as follows: the reaction mixture (1 ml) containing 2 M HMP in 0.1 
M pH 7.0, 1mM EDTA and 20 % v/v ethanol, 140 M linoleic acid hydroperoxide and  500 
M NADH was allowed to stand 15 minutes under a nitrogen gas atmosphere at 25 °C.  At 
the end of the reaction, the solution was treated with 2 ml of ethylacetate, vortexed and 
centrifuged at 6000 rpm for 15 minutes. Two blank solutions were prepared in which either 
NADH or HMP were omitted. The ethylacetate extracts were dried under vacum and 
resuspended in 80% ethanol/water containing 0.5% v/v ammonia. The ethanolic solutions 
were analyzed by infusion (5 l/min) in an electrospray ion trap mass spectrometer (ES-IT, 
mod. LCQ, ThermoFinnigan, San Jose, CA, USA). Linoleic hydroperoxide standards, 
dissolved in the same solvent, were used to optimize the ESI source parameters. The mass 
spectra were collected over the mass range of 70-700 a.m.u., in negative ion mode. 
 
2.3.4 Gel filtration analysis 
Gel filtration experiments were carried out according to Chiancone et al. (1974). A 
Sephadex G-75 (Pharmacia, Uppsala Sweden) column (0.5×35 cm) was used at a constant 
flow rate of  5 ml/h and at 20 °C. All experiments were carried out in 50 mM phosphate 
buffer at pH 7.0. 0.2 ml of a protein solution (25 M) were applied on the column and the 
elution profiles was monitored in the Soret region with a Jasco 7800 spectrophotometer 
equipped with a thermostatted flow cell. Column calibration was determined by using native 
human hemoglobin tetramer (carbonmonoxy derivative) and horse heart myoglobin. 
Liposomes were obtained from dried TLE resuspended in 10 ml of 50 mM phosphate buffer 
at pH 7.0, heated at 60 °C for 15 minutes and then sonicated in a Soniprep 150 sonicator for 
30 minutes. The liposomes thus obtained were left 4 h at 4 °C, pelleted by centrifugation and 
resuspended in buffer before use. Phospholipid content in TLE was determined by FTIR  
absorption of the carboxyl ester at 1735 cm-1 on a weighted amount of dry TLE dissolved in 
chloroform with respect to a phosphatidylethanolamine standard (Sigma Aldrich Co.). 
Liposome solutions (0.4 ml) containing 20:1 phospholipid/protein molar excess were mixed 
with 0.1 ml of HMP solutions (25 M) and then applied on the G-75 column. Horse Mb 
(Sigma Aldrich Co.) was also run in gel filtration experiments in the presence of TLE as a 
control.  
 
2.3.5 UV-Visible and near infrared absorption spectroscopy 
Absorption spectra were recorded either on a Jasco V-570 spectrophotometer (Jasco 
Ltd, Japan) or on a Hp 8452 diode array spectrophotometer. Single crystal spectra were 
measured with a 4DX ray System AB microspectrophotometer (Wilmot et al. 2002). 
 
2.3.6 Resonance Raman spectroscopy 
The experiments were carried out in the lab of prof. Giulietta Smulevich at the 
Department of Chemistry, University of Florence. Resonance Raman (RR) spectra were 
obtained at room temperature with excitation from the 406.7 nm line of a Kr+ laser (Coherent, 
Innova 302). The back-scattered light from a slowly rotating NMR tube was collected and 
focused into a computer-controlled double monochromator (Jobin-Yvon HG2S) equipped 
with a cooled photomultiplier (RCA C31034A) and photon counting electronics. RR spectra 
were calibrated to an accuracy of 1 cm−1 for intense isolated bands with indene as the standard 
for the high-frequency region and with indene and CCl4 for the low-frequency region.  
 
2.3.7 X-ray absorption spectroscopy 
Fe K-edge X-ray absorption spectra of lipid-free and lipid-bound HMP were collected 
in fluorescence mode at the BM30-B (FAME) beam line of the ESRF synchrotron facility. 
The HMP samples were in 1:3 glycerol-water solutions buffered at  pH 7 (50 mM phosphate). 
 The final iron concentration was 4mM and the spectra were collected at 40 K. The met-
myoglobin (aquo-MetMb) solution was 7 mM (heme) in the same buffer. The storage ring 
was running in the 2/3 filling mode with a typical current of 170 mA. The monochromator 
was equipped with a Si (111) double crystal, in which the second crystal was elastically bent 
to a cylindrical cross section. The energy resolution at the Fe-K edge is 0.5 eV. The X-ray 
photon beam was vertically focused by a Ni-Pt mirror, and dynamically sagittally focused in 
the horizontal size. An array detector made by 24 Ge elements of very high purity was used. 
For each sample 10 spectra were recorded with a 7s/point collection statistic and averaged. 
The spectra were calibrated by assigning the first inflection point of the Fe foil spectrum to 
7111.2 eV. 
 
 
2.4 LIGAND BINDING STUDIES 
 
2.4.1 Ligand binding equlibria 
Titration experiments were carried out by adding small volumes of imidazole (Sigma 
Aldrich Co.) solutions to the protein solution (8 M) in 0.1 M sodium phosphate buffer at pH 
7.0 and 20 °C in a 1 cm quartz cuvette. Imidazole titration experiments were carried out on 
both lipid free and lipid (UFA, CFA or TLE) saturated ferric protein.  
 
2.4.2 Ligand binding kinetics 
2.4.2.1 Lipid binding to ferric HMP 
Purified, lipid free protein has been screened for heme visible absorption spectral 
changes against a number of phospolipids (dipalmitoil phosphatidil choline, dipalmitoil 
phosphatidil ethanolamine, dipalmitoil phosphatidic acid), saturated (palmitic and stearic), 
unsaturated (oleic, palmitoleic, linoleic, cis vaccenic) and cyclopropanated (9,10 methylen 
palmitoleic) fatty acids and their methyl esters, aromatic hydrocarbons (benzene, toluene, 
naftalene), linear and cyclic alkenes (1 dodecene, 6 dodecene, cyclohexene, cyclooctene). The 
screening was performed on 8-12 M protein solutions in 0.1 M phosphate buffer at pH 7.0 
and 20 °C containing 20 % v/v ethanol by adding increasing amounts of ligand (1 to 100 
molar excess) dissolved in ethanol. All reagents were from Sigma Aldrich Co. with the 
exception of cyclopropan palmitoleic acid (Larodan Fine Chemicals, Malmö, Sweden).  
Fatty acid binding kinetics were performed by mixing 5 M HMP in 0.1 M phosphate 
buffer at pH 7.0 and 20 °C containing 20 % v/v ethanol with a solution containing increasing 
amounts of palmitoleic, cyclopropanpalmitoleic or linoleic acid, dissolved in the same buffer, 
in an Applied Photophysics stopped flow apparatus (Leatherhead, U.K.). Fatty acid release 
kinetics were estimated in competition essays with the lipid avid hydroxylalkoxypropyl-
dextrane resin (Tipe X, Sigma Aldrich Co.). 5 ml of a gel suspension containing 20 mg of 
dried resin in 0.1 M phosphate buffer at pH 7.0 and 20 % v/v ethanol were placed in a small 
beaker under stirring at 20 °C. The fiber optic “Dip Probe” of a Varian Cary 50 
spectrophopometer, equipped with a 150 W pulsed Xe lamp, (Varian Instrument Co. 
Australia) was immersed in the suspension and a baseline was recorded. A HMP solution 
(100 l, 160 M) saturated with oleic, cyclopropan-palmitoleic or linoleic acid was then 
added to the suspension and spectra were measured in sequential mode (9 s for each 
spectrum). Fatty acid release was monitored by following the spectral changes in the Soret 
region. 
 
2.4.2.2 Imidazole binding to ferric HMP 
Ligand combination kinetics of imidazole were carried out by mixing the lipid free or 
TLE saturated protein solutions (6-8 M) with imidazole solutions in an Applied 
photophysics rapid mixing apparatus (Applied Photophysics, Leatherhead, UK). 
 In order to single out the rate constants of Schemes II (see Results, Fig. 16), the 
following procedure was adopted: i) only the spectral transitions involving imidazole binding 
or release to the heme site are considered to contribute to the observed signal; ii) the set of 
imidazole combination time courses were fitted to the Scheme II by fixing the equilibrium 
thermodynamic constants to the values obtained in the imidazole titration experiment. In this 
fitting procedure it was assumed that the intramolecular process determined by K3 is much 
faster with respect to the other processes. Hence, four rate constants, namely k1, k2, k4 and k5 
were allowed to float. The total  absorbances were fixed, for each time course, to the 
equilibrium values. The Matlab 5.0 program (The Math Works Inc. South Natick, MA) was 
used in all least squares fitting procedures. 
 
2.4.2.3 Ligand binding to ferrous HMP 
Oxygen release kinetics were carried out according to the oxygen pulse method (Boffi 
et al. 2004). Briefly, the protein solutions containing 10-50 mM sodium dithionite were mixed 
with oxygen containing buffer. Oxygen binding to the heme iron occurs within the dead time 
of the instrument (4 ms) and is subsequently released due to the rapid reaction of oxygen itself 
with dithionite to produce higher sulphur oxides. Thus, the observed spectral signal pertains 
to the formation of deoxy heme and is monitored at the relevant Soret peak around 434 nm or 
at 415 nm (the peak of the oxygenated species). Slower absorbance changes (a decrease at 
434 nm and an increase at 420 nm) were observed over tens of minutes time scale and were 
attributed to the binding of some dithionite byproducts to the heme iron and the subsequent 
formation of a hemochrome-like species. Such effects are dithionite concentration dependent 
and are negligible up to 50 mM dithionite. It was also observed that aged protein solutions 
(frozen at -70 °C for three months) exhibited almost complete hemochrome formation within 
few minutes from dithionite addition. On the basis of these observations, oxygen pulse 
experiments were carried out on freshly prepared protein and were shown to be fully 
reproducible in different preparations up to 50-100 mM dithionite.  
The CO binding kinetics of HMP were measured in oxygen free solutions at pH 7.0 
(0.1 M phosphate buffer), in the presence of 1 mM EDTA and 250 M NADH, and 20.0 °C 
by laser photolysis. The HMP solution containing NADH was accurately degassed in a 
tonometer until the fully deoxy species is formed. Thereafter, the solution was equilibrated 
with CO gas at 20 °C to a final equilibrium concentration of 1 to 0.025 mM. The 
measurements have been carried out using as an optical pump the second harmonic from a 
Quanta System Nd-YAG laser ( = 532 nm, frequency of 2 Hz with pulse width of 5 ns and 
pulse energy of approximately 80 mJ). The laser pulse flashes the sample in a tonometer with 
a fluorescence quartz cell of 1 cm length orthogonally to the optical probe due to a 100 W 
UV-visible source focused onto a monochromator SPEX 1681. Single wavelength 
measurements have been acquired using as detector a photomultiplier tube Hamamatsu 
H6870. The time courses (average of 64 traces) were recorded using a digital oscilloscope 
Tektronix TDS 360. The time courses were followed at 434 nm, as a function of CO 
concentration (ranging between 1 and 0.025 mM) at a protein concentration of  4 M. 
 
2.4.2.4 Enzyme kinetics 
Enzyme kinetic measurements were carried out by mixing anaerobic protein solutions 
containing 250 mM NADH and 1 mM EDTA with solutions containing different 
concentrations of tert-butyl, cumyl, linoleic acid hydroperoxides (13(S) hydroperoxy 9Z,11E 
octadecadienoic acid) or hydrogen peroxide (Sigma Aldrich Co.) in an Applied Photophysics 
rapid mixing apparatus equipped with a diode array device (Leatherhead, UK). Stock 
solutions of tert-butyl, cumyl and linoleic acid hydroperoxide were prepared in 50% 
water/ethanol mixtures, degassed in a tonometer and kept at 4 °C in the dark before use. 
Solutions containing HMP and NADH and solution containing hydroperoxides were 
accurately degassed in a tonometer and anaerobically transferred to stopped flow syringes. 
 The syringes containing HMP and NADH were allowed to stand for 5 minutes before mixing 
in order to ensure the consumption of residual oxygen. Double mixing experiments were also 
carried out in the same stopped flow apparatus: NADH (250 µM) reduced HMP (8 µM) was 
first mixed with H2O2 in the pre-mixing chamber and, after a 2 s delay,  with 20-1000 M 
CO (oxygen free) solutions. Alternatively, slower kinetic time courses at low protein 
concentrations (below 1 M) were carried out by mixing the NADH reduced protein with the 
alkylhydroperoxide solutions directly in a tonometer equipped with a 1 cm quartz cuvette and 
a side arm reservoir. In CO inhibition experiments, a few l of a CO gas saturated solution 
were added to the tonometer with a microsyringe and equilibrated for 20 min with the 
acqueous phase before adding the substrate to yield an equilibrium CO concentration of 1-20 
M. Time courses were followed at 340 nm (absorption maximum of NADH) on a Jasco V-
570 spectrophotometer. All experiments were carried out in 0.1 M phosphate buffer at pH 7.0 
containing 1 mM EDTA and at 25 °C. In the case of linoleic acid hydroperoxide, reaction 
kinetics were carried out in the presence of either 0.1 % Triton X-100 or 20 % v/v 
ethanol/water mixture.  
 3. RESULTS 
 
3.1 ANALYSIS OF THE THREE DIMENSIONAL STRUCTURE 
 
3.1.1 The overall fold 
The overall fold of HMP (Fig. 1) consists of heart shaped structure in which three 
different domains, namely the C-terminal NAD-binding domain, the FAD-binding domain 
and the N-terminal globin domain are clearly distinguished.  
 
  
 
The tridimensional structure of HMP is compared to that of Alcaligenes eutrophus 
flavohemoglobin (FHP), formerly obtained by Ermler et al. (1995). In spite of the high degree 
of sequence similarity between HMP and FHP, the superposition of the two structures 
obtained with the program Spdb viewer, results in a high root mean square deviation (6.83 Å). 
Such a deviation is due mainly to a rotation of the NAD-binding module (see Fig. 2, panel A) 
and to a substantial rearrangement of the E helix positioning within the globin domain in 
HMP with respect to FHP. It is important to point out that the HMP structure has been 
obtained on the fully oxidized protein (i.e. heme-iron in the ferric state and oxidized flavin), 
whereas the structure of FHP was determined on the fully reduced protein (i.e. heme-iron in 
the ferrous state and reduced flavin). 
 
                             
 
Fig. 2 Structural overlay of the globin domains of Escherichia coli and Alcaligenes eutrophus 
flavohemoglobin and Vitreoscilla sp. hemoglobin. 
The overlay among globin domains was obtained by minimizing the Cα distances for each protein using the 
program Spdb viewer. The stereo  diagram of the globin domain of HMP (red ribbons, yellow heme) is 
overlayed with the corresponding domain of Alcaligenes eutrophus flavohemoglobin (green ribbons, green 
heme) in panel A and with Vitreoscilla Hb (cyan ribbons, blue heme) in panel B. 
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Fig. 1 Overall structure of Escherichia 
coli ferric unliganded flavohemoglobin. 
The heart shaped structure is positioned 
with the flavin binding domain at the upper 
apex (cyan), the globin domain on the 
lower right side (red) and the NAD-binding 
domain on the lower left side (green) 
(panel A). The ribbon diagram was 
depicted using the program MOLSCRIPT 
 3.1.2 The globin domain. 
The architecture of the globin domain corresponds to a classical globin fold composed 
of eight helices (from A to H) with an unusually long H helix and in which the D helix is 
substituted by a large loop region within the segment CD2-E6 (Asn44 to Asp52). Apart from 
the invariant residues PheCD1 and HisF8, considered as the hallmark of the globin structure, 
the heme pocket geometry show little resemblance to that observed in vertebrate hemoglobins 
and myoglobins. Inspection of the distal pocket architecture reveals that the distal position, 
closest to the iron atom, is occupied by the Leu57 (E11) isopropyl side chain with the CG 
atom at 3.6 Å distance from the iron atom along the normal to the heme plane (Fig. 3). Leu-
E11 side chain together with the Phe-CD1 ring, the Ile61 (E15) and Val98 (G8) side chains 
and the Gln53 (E7) backbone segment, fill completely the first distal shell (Fig. 3). In 
contrast, Tyr29 (B10) and Gln-E7 side chains, previously proposed as the major candidates 
for iron-ligand distal stabilization (Peterson et al. 1997, Ermler et al. 1995), are shifted from 
the heme at a distance of more than 5.0 Å. The Tyr B10 phenol ring is confined to the second 
layer of distal pocket residues with the phenol hydroxyl pointing towards the isopropyl chain 
of Leu E11.  
 
 
             
 
 
The architecture of the heme pocket in the proximal region is characterized by the 
presence of the canonical proximal histidine (His F8) residue whose Nδ atom coordinates the 
ferric heme iron at 2.01 Å distance. However, at variance with vertebrate hemoglobins, the 
proximal histidine is  involved in a hydrogen bonding network between His85 (F8), Tyr95 
(G5) and Glu135 (H23) (see Fig. 3) that imparts a rigid orientation to the imidazole histidine 
ring with respect to the heme plane. In particular, the OE2 atom of Glu135 is involved in a 
hydrogen bonding interaction at 2.9 Å from the ND1 nitrogen of the proximal histidine. In 
turn, Glu135 is anchored to the phenol hydroxyl of Tyr95 by a hydrogen bonding (OE2 at 2.7 
Å from the Tyr oxygen atom).  
Another peculiar structural feature of the HMP heme domain consists in the 
arrangement of the CE loop region. In fact, as shown in Fig. 4, the cavity formed by the 
residues Asn44-Asp52 is filled with a strong electron density whose electronic shell most 
likely pertains to a large anion such as chloride or phosphate. Possible electrostatic 
interactions to the bound anion have also been identified and include a positively charged 
ammonium ion belonging to residues Arg49, amide nitrogen of Asp52 and Arg54 and/or to 
the O2D oxygen atom of a heme propionate.  
 
 
Fig. 3 Structural details of the heme 
pocket in Escherichia coli ferric 
unliganded flavohemoglobin. 
The heme molecule is shown together with 
a selection of aminoacid residues within the 
pocket at 5 Å from the macrocycle. The 
phenolic ring of  Tyr29 (B10), located at 
more than 5 Å form the heme, is also 
shown whereas the Phe43 (CD1) is hidden 
for clarity. The picture was obtained with 
the program MOLSCRIPT. 
             
 
This finding is of particular interest due to the location of the loop on the heme edge 
towards the propionate region and in contact with the flavin binding module. A possible 
functional implication of the anion binding site in modulating the heme ligand binding 
properties will be discussed later.  
 
3.1.2.1 Comparison between E. coli and A. eutrophus globin domain. 
The structural overlay of the Cα skeleton of HMP and FHP globin domains indicates 
that a major difference between the two proteins pertains to the positioning of the E helix that 
is shifted far from the heme plane in the latter protein (Fig. 2A). The structural overlay 
between the two proteins demonstrates clearly that in FHP heme domain the E helix shift is 
determined by the accomodation of a bulky phospholipid molecule that alters the positioning 
of the relevant distal pocket residues (Ollesch et al 1999). In particular, in FHP, the 
cyclopropane ring of a 9,10-methylen-hexadecanoic chain of a dyacylglycerol-phosphatidic 
acid (a common fatty acid component within the bacterial membranes) sits on the top of the 
iron atom apparently displacing the relevant distal site residues. In fact, in FHP, Leu-E11 
accompanies the lipid induced E helix movement and is displaced by 4.6 Å away from the 
heme pocket with respect to its positioning in HMP.  Interestingly, HMP is also capable of 
binding membrane lipids, although with lower affinity with respect to FHP (Ollesch et al. 
1999) and VHB has also been recently reported to be able to interact with the bacterial inner 
membrane (Ramandeep et al. 2001). Taken together, these observations suggest that lipid 
binding is not a distinctive feature of FHP but may represent a common property of the 
bacterial hemoglobin family, the functional role of which is still to be defined. 
 
3.1.2.2 Comparison between HMP heme domain and Vitroscilla Hb. 
The striking similarity of the overall fold of the heme domain in HMP and Vitreoscilla 
Hb (Cα structure superposition rmsd = 1.58) shown in Fig. 2B, is not reflected in a similar 
architecture of the distal heme pocket in that notable differences concern the nature and/or the 
geometry of the E8 and E11 topological positions. The proline ring in position E8 in VHB lies 
close to the heme plane normal at 3.8 Å from the metal in the distal pocket (Tarricone et al. 
1997), but is substituted by an arginine residue in HMP whose side chain is oriented outside 
the distal pocket. Leu-E11, in HMP, occupies a genuine distal site position along the normal 
to the heme plane whereas the same residue, in VHB, is in a staggered conformation and 
appears to line the edge of the heme (Tarricone et al. 1997, Bolognesi et al. 1999). In both 
Fig. 4 Electron density map of the 
CE  region of Escherichia coli
heme domain.  
Electron densities were calculated 
with the program XPLOR (Brünger 
et al. 1992) and contoured at 1σ
from the residues A44-A56. The 
anion residing at the center of the 
map was tentatively assigned to a 
chloride ion (yellow sphere). 
 
 HMP and VHB the Gln E7 side chain does not contribute to the formation of the first distal 
pocket shell in the unliganded derivatives. 
  
3.1.2.3 The FAD binding domain   
 The structures of the FAD- and NAD-binding modules in HMP are superimposable to 
those observed in FHP. The former consists of a six-stranded antiparallel β-barrel with Greek 
key topology capped by a helix at the bottom and an irregular peptide at the top. The latter is 
built up of a five-stranded parallel β sheet flanked by two helices on the one side and by one 
helix and an irregular structural element  on the other. The FAD-binding and NAD-binding 
domains are fused to build the so-called oxidoreductase module, which structurally belongs to 
the ferredoxine reductase family. 
Nevertheless, two major differences between HMP and FHP need to be considered 
further. First, as shown in Fig. 2A, the relative orientations of the FAD- and NAD-binding 
domains in the two proteins differ. In particular, the entire NAD-binding domain in HMP is 
rotated clockwise with respect to the relative orientation observed in FHP thus leading to a 
considerably larger interdomain cleft in HMP. The second point concerns the structural 
arrangement of the isoalloxazine binding motif. The si-side geometry is strikingly similar in 
the two proteins in that the segment 205-207 (207-209 in FHP) and the Tyr188 (190 in FHP) 
exhibit identical orientations with respect to the isoalloxazine plane (see Fig. 5). Other 
conserved contacts (not shown) to  
 
 
                                     
 
Fig. 5 Structural details of the FAD binding site in Escherichia coli ferric unliganded (right) and 
Alcaligenes eutrophus ferrous, lipid bound (left), flavohemoglobins. 
The isoalloxazine three membered ring (embedded in a transparent Van der Waals surface) is shown together 
with a selection of aminoacid residues located within 5 Å distance from the macrocycle atoms in the re-side 
(top) and in the si-side (bottom). Pictures were obtained with the program ViewerLite. 
  
 
the flavin moiety involves Val269 in HMP (276 in FHP) and Thr272 (279 in FHP). In 
contrast, the re-side, that faces the C-terminus loop region of the NAD-binding domain, is 
quite different in the two proteins. In fact, in HMP, the aromatic ring of the conserved Phe390 
(396 in A. eutrophus) is packed against the isoalloxazine central ring whereas in FHP it 
protrudes towards the interdomain cleft. Considering the high sequence similarity within the 
FAD- and NAD-binding domains of the two proteins, both the rotation of the NAD-domain 
 and the differences in the re-side of the isoalloxazine binding motif may be suggestive of a 
conformational change linked to the binding of a phospholipid molecule. Thus, it may be 
envisaged that the lipid free species is stabilized by a stacking interaction of the isoalloxazine 
ring with Phe390 (in HMP) whereas, upon lipid binding (i.e. in FHP), the whole C-terminus 
loop is shifted and rotated towards the ribitol moiety with concomitant loss of the stacking 
interaction. In spite of these significant structural rearrangements, the relative positioning of 
the isoalloxazine moiety and the heme plane are superimposable in the two proteins and only 
a modest decrease in the closest distance between the two cofactors is observed (the distance 
between the C8AF atom of the isoalloxazine and OA1 of the heme propionate is 6.3 Å in FHP 
and 5.9 Å in HMP).  
 
 
3.2 ALIGNMENTS 
More than 50 putative flavohemoglobins have been identified trough a BLAST 
research on bacterial and eukaryotic genomes. A phylogenetic analysis of these proteins has 
been performed using  CLUSTAL W (1.75) Multiple Sequence Alignment as shown in Fig. 6.  
 
 
 
Fig. 6 Phylogenetic trees showing the relationship among flavoHbs.  
The distance trees have been constructed aligning HMP with bacterial (panel A) and eukaryotic (panel B) 
flavohemoglobins using CLUSTAL W (1.75) Multiple sequence alignment . The program is freely available at 
http://www.es.embnet.org/cgi-bin/clustal.cgi. 
There is a number of aminoacids that are strictly conserved among all these proteins within both the 
heme and the FAD binding domains (Fig. 7).  
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Fig. 7 Conserved residues within the flavohaemoglobin family. 
HMP heme domain (panel A) and flavin domain (panel B) are shown. The stick pictured aminoacids represent 
residues conserved among  all flavohemoglobins identified so far. Pictures were obtained with the program 
ViewerLite. 
 
 
Invariant residues close to the heme cofactor correspond to Phe28 (B9), Tyr29 (B10), 
Phe43 (CD1), Gln53 (E7), Leu57 (E11), Asn44, Val98, Leu102 and Tyr124 on the heme 
distal side and His85 (F8), Glu135, Tyr95 and Lys84 on the heme proximal side of 
Escherichia coli flavohemoglobin. Phe43 is absolutely conserved in all species and its 
aromatic side chain binds nearly parallel to the heme plane. The proximal histidine (His F8) is 
also invariant in all known globin sequences, even if its environment changes remarkably. 
Within the flavohemoglobin family this histidine is hydrogen bond to the conserved Glu135 
and Tyr95. The distal Tyr29 and Gln53 are supposed to be involved the stabilization of the 
oxygen bound to the heme iron. Finally, Phe28, Leu57, Val98 and Tyr124 seem to be 
involved in phospholipid binding. 
The conserved aminoacids of the flavin domains correspond to residues: Phe290, 
Gly270, Glu388, Thr272, Pro273, Gly186, Gln187, Tyr188 and Ser23. These residues occupy 
topological positions that are highly distinctive of ferredoxin (or flavodoxin) reductases, a 
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 subfamily of flavin binding proteins that is highly specialized in electron transfer from the 
NADH cofactor to the flavin moiety and to a high redox potential electron acceptor, tipically 
a ferredoxin. Consistently, the conserved residues appear to contour and shape the flavin 
binding cavity thus reducing solvent access and providing the structural basis for the 
interaction with NADH as a substrate.      
 
 
3.3 LIPID BINDING PROPERTIES 
The interaction of bacterial Hbs with membranes has been first proposed for 
Vitreoscilla Hb, that has been demonstrated to bind the inner membrane and act as a 
facilitator of oxygen transfer by placing it closest to respiratory chain. A. eutrophus 
flavohemoglobin is also able to bind phospholipids as observed in the X-ray structure that 
shows, adjacent to the heme molecule, an unexpected electron density originally designated as 
an unknown ligand (Ermler et al. 1995). Later, the nature of this ligand was identified as a 
phospholipids (Ollesch et al. 1999). The X-ray structure of HMP not only revealed a high 
degree of similarity with the VHB and FHP, but also showed that the aminoacids involved in 
the binding of the lipid are strictly conserved.  
On the basis of these data, the fatty acids and phospholipids binding properties of 
HMP in solution were investigated both by thermodynamic and kinetic methods. 
 
3.3.1 Gel filtration analysis 
We have shown that Escherichia coli flavohemoglobin is able to bind reversibly a 
number of unsaturated and cyclopropanated phospholipids and fatty acids (UFA and CFA) as 
well as liposomes obtained from Escherichia coli total lipid extracts (TLE). HMP binding to 
different types of liposomes was tested by means of gel filtration chromatography. The 
elution profiles reported in Fig. 8 were obtained by measuring the absorption of the G-75 
column elute at the HMP Soret peak (405 for the ferric derivative and 420 nm for the CO 
bound ferrous derivative). The peak at 8.22 ml corresponds to the void volume as measured 
by dextran blue (profile 1). Liposomes are also eluted within the void volume as demonstrated 
by the slight absorbance increase around 8.3 ml (profile 5). Experiments carried out with 
freshly prepared TLE liposomes and horse Mb (ferric) indicated that the protein does not 
interact with the membranes and that no heme is released to the lipid bilayer under the present 
experimental conditions (profile 2). In apparent contrast, Ramandeep et al. (Ramandeep et al. 
2001) reported a weak but detectable interaction of both horse Mb and human hemoglobin 
with bacterial membranes. However, their size exclusion measurements were at equilibrium, 
(i.e. there was no mobile solvent phase through the gel matrix) whereas the present classical 
gel filtration experiment implies that even interacting particles (i.e. liposomes and Mb) can be 
sieved depending on their molecular mass if their interaction is weak. Thus, the present 
experiments cannot exclude a weak interaction between Mb and lipid bilayers. Moreover, 
heme release from ferric Mb to liposomes has been shown to be negligible at pH 7.0 and 20 
°C whereas it does occur at pH values below 5.0 and temperature higher than 25 °C 
(unpublished data). In turn, the elution profile of HMP in the presence of TLE liposomes 
(profile 3) displays two separate peaks at 8.3 and 11.7 ml respectively, whose integrated 
surfaces account for 55% and 45 % of the total area. The peak at 8.3 ml contains both the TLE 
liposome fraction and ferric HMP whereas the peak at 11.7 corresponds to the elution volume 
of free HMP. The absorption spectra of the two fractions, shown in panels a and b of Fig. 8, 
correspond to the spectrum of ferric, lipid bound, HMP (see also Fig. 9). The gel filtration 
data indicate clearly that HMP is not only capable of strong binding to liposomes obtained 
from E. coli lipid extracts (TLE) but may also abstract phospholipids from the liposome 
fraction, although it cannot be excluded that free, monodisperse lipids might be present in the 
liposome preparation even after centrifugation. Mass spectrometric analysis performed on the 
second fraction revealed the presence of heterogeneous phospholipid species. The nature of 
 the bound phospholipid, however, cannot be assessed with certainty due to the intrinsinc 
heterogeneity of the sn-1 and sn-2 glycerol linked components. As a control, purified, lipid 
free HMP was also screened towards dipalmitoil phosphatidil choline vescicles and only a 
negligible interaction has been detected (profile 4). 
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Fig. 8 Elution profiles of E. coli flavohemoglobin on a gel filtration column in the presence of  liposomes. 
From top to bottom: standard solution composed of of blue dextran (the arrows correspond to the excluded 
volume), carbonmonoxy human hemoglobin (HbA) and horse heart myoglobin (Mb) (profile 1); ferric Mb mixed 
with total lipid extracts (TLE) from E. coli cells (profile 2); purified ferric unliganded HMP mixed with 
liposomes (20:1 phospholipid/protein molar ratio) obtained from E. coli total lipid extracts (profile 3); purified 
ferric unliganded HMP mixed with DPPC liposomes (20:1 phospholipid protein molar ratio) (profile 4); TLE 
liposomes (profile 5). The absorption spectra of the eluates relative to profiles 3 and 4 are also shown in panels a, 
b, and c, respectively. Experiments were carried out on a G-75 Sephadex column equilibrated with 50 mM 
phosphate buffer at pH 7.0 and 20 °C.  
 
 
3.3.2 Spectroscopic properties. 
In order to gain full understanding of the complex relationship between HMP and 
phospholipids the structural nature of protein-lipid interactions need to be explored. 
Nevertheless, in spite of considerable efforts, crystallization of lipid bound HMP could not be 
achieved under the experimental conditions in which the lipid free derivative easily yields a 
number of small hexagonal crystals. For these reasons the fine structural aspects of HMP-lipid 
interaction have been investigated by means of EXAFS, resonance Raman and UV-Vis 
spectroscopy. 
 
3.3.2.1 UV-Vis absorption spectra of the lipid bound derivative 
The present investigation originated from the observation of spectral changes in ferric 
HMP noticed during the protein purification procedure and initially attributed to the loss of 
flavin from the holoprotein. In particular, the visible absorption spectra of HMP before and 
after hydroxylapatite chromatography were different (see below). Electrospray mass 
spectrometry, performed on the protein before hydroxylapatite chromatography, revealed the 
 presence of heterogeneous protein-linked components attributed to phosphatidyl ethanol 
amine and phosphatidic acid derivatives, in full agreement with the report by Ollesch et al. 
(1999). Further inspection on the fatty acid methyl esters obtained from HMP-bound 
phospholipids shows the nature of the estherified fatty acids, that are palmitic acid and C16 or 
C18 unsaturated or cyclopropanated chains.  
In Fig. 9 the unliganded and linoleic acid bound derivatives are shown. The absorption 
spectra of the unliganded derivatives display a broad Soret band, characterized by a low molar 
absorptivity and centered at 403 nm. In the visible region, a prominent charge transfer band 
(CT 1) is observed at 645 nm both in solution and in the crystal. The solution spectra of HMP 
saturated with free unsaturated fatty acids or phospholipids displays a sharp peak at 407 nm 
and a CT 1 at 625 nm. This last spectrum was superimposable to that observed in the ferric 
protein before hydroxylapatite chromatography thus providing evidence that bound 
phospholipids are removed by this chromatographic step. The spectral changes observed upon 
lipid binding or release were also reproduced upon removal of the lipid species by means of 
hydrophobic chromatography (hydroxyalkoxypropyl-dextrane) thus demonstrating that the 
lipid binding is fully reversible. 
 
 
Fig. 9 UV-Visible absorption spectra of ferric Escherichia coli flavohemoglobin and its heme domain. 
The spectra of the ligand free (thin line) and linoleic acid bound (thick line) HMP heme domain are collected in 
panel A. The spectra of the ligand free (thin line) and linoleic acid bound (thick line) full length HMP are 
collected in panel B together with the spectrum of ligand free HMP in the crystal (dashed line). All spectra are in 
0.1 M phosphate buffer at pH 7.0.  
 
 
3.3.2.2 RR spectra  of the lipid bound derivative 
RR spectra reported in Fig. 10 have been obtained on the HMP heme domain. Full 
length HMP could not be safely analyzed with the 406.7 nm excitation  due to the strong 
flavin absorption at this wavelength  and hence to the possible photoreduction of the flavin 
itself. The RR high frequency region (Fig. 10, panel B) in which coordination and spin state 
marker bands are apparent is almost identical to that obtained by Mukai et al. (2001) on the 
full length protein. It displays the typical features of a ferric, high spin, pentacoordinate 
derivative with a υ3 band at 1492 cm-1, a υ2 peak at 1567 cm-1  and υ10 at about 1630 cm-1 
 overlapped with vinyl stretching modes at 1623-1630 cm-1. Upon linoleic acid or TLE binding 
(spectra b and c, respectively) the core size marker bands shift to 1478 cm-1 (υ3), 1560 cm-1 
(υ2) and 1606 cm-1 (υ10). In addition, a band at 1516 cm-1 is clearly observed (υ37). These 
frequencies correspond to those observed for six coordinate, high spin, heme iron complexes 
(Spiro 1985). The low frequency region (Fig. 10, panel A) displays intriguing spectral 
features in that lipid binding is accompanied by a strong enhancement of the 319 cm-1 peak 
with a shoulder at 305 cm-1. These bands are observed at the same frequencies both with 
linoleic acid and with TLE phospholipids (containing mainly cyclopropanated fatty acids) 
thus indicating that they do not likely originate from an iron ligand stretching mode. Thus, the 
319 cm-1 and 305 cm-1 bands are tentatively assigned to the γ6 and γ7 out of plane modes of the 
heme skeleton in analogy with myoglobin whose frequencies are observed at 337 and 305 cm-
1, respectively (Hu et al. 1996). However, their enhancement in the spectra of the 
hexacoordinate high spin heme iron is unexpected since these modes are known to be 
preferentially RR active in distorted hemes, such as pentacoordinate heme (Smulevich et al. 
1996). 
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Fig. 10 Resonance Raman spectra of ferric Escherichia coli flavohemoglobin heme domain. 
Spectra in the high frequency (panel A) and low frequency (Panel B) region of  lipid free ferric HMP (a), linoleic 
acid bound HMP (b) and TLE saturated HMP (c). The protein concentration was 90 µM in (a) and (b) and 35 
µM in (c). Buffer was 0.1 M phosphate buffer at pH 7.0. Experimental conditions: 16 mW laser power at the 
sample, 5 cm-1 resolution. The accumulation interval ranges from 4 s / 0.5 cm-1 to 16 s / 0.5 cm-1. 
  
 
3.3.2.3 EXAFS spectra  of the lipid bound derivative 
The Fourier transform (FT moduli) of the EXAFS spectra corresponding to lipid free 
HMP, (HMP_LF, solid curve), lipid bound HMP (HMP_LB, dashed curve) and aquo-MetMb 
(dotted curve), extracted with a cubic spline, are shown in Fig. 11, lower panel. The FTs have 
been calculated in the interval k = 3.2-10.0 Å-1 with no phase-shift correction applied. The 
spectral intensity (absorption) are plotted as a function of R, which represents the distance 
from the scattering element (i.e. from the iron 2p electron shell) and thus reflects the distance 
among the iron atom and the nearby nuclei within about 4 Å.  
 
    
 
 
Thus, the high intensity peaks around R=1.5 Å are associated with the atoms from the first 
coordination shell around the iron atom. In the case of lipid free HMP it comprises four 
pyrrolic nitrogen atoms of the porphyrin ring (Np) and one nitrogen atom of the proximal 
histidine (Nh). An additional oxygen atom contributes to this peak in the case of aquo-MetMb. 
The second set of peaks, between R values of 2 and 3.5 Å contain all the single and multiple 
scattering contributions associated with the carbon atoms in the second coordination shell of 
both the porphyrin plane and the proximal histidine. According to the crystallographic 
structure, the distal site of the heme iron in HMP is occupied by the isopropyl side chain of 
the LeuE11. Therefore, two additional carbon atoms of this residue contribute to the second 
peak of the lipid free HMP FT spectrum at about 3.5 Å. The third set of peaks beyond 3.5 Å is 
mainly due to the single and multiple scattering contributions associated with the third shell of 
the tetrapyrrole macrocycle atoms.  
Simple inspection of the EXAFS spectra offers interesting insight into the structural 
changes that accompany lipid binding to HMP. It can be noticed that both the position and 
intensity of the first EXAFS peaks of liganded and unliganded HMP are identical. However, 
the right-hand shoulder of the first EXAFS peak is increased and the amplitude of the second 
peak at R = 3 Å is decreased in the liganded derivative. All together these observations 
indicate that a structural change of the Fe environment occurs at the axial site in the presence 
of the lipid within a R value in the range 2.5-3.5 Å. Data analysis showed that a binding 
interaction occurs between the ferric heme iron and a couple of atoms located at 2.7 Å from 
the metal indicating that the ferric heme is clearly hexacoordinated. Nevertheless, inspection 
of the crystal structure of the ferrous, lipid bound, A. Eutropus FHP (1.75 Å resolution) 
indicates that the iron-nearest carbon atom (CA of the cyclopropane ring, see Fig. 12) in 
ferrous, lipid bound, FHP is at 3.5 Å distance from the metal. Such distance precludes any 
bonding interaction between the iron atom and the distal ligand in that no orbital overlap can 
be predicted to occur involving the dz2 ferrous or ferric iron orbital at a distance higher than 
Fig. 11 Fe K-edge XANES 
spectra of Escherichia coli 
flavohemoglobin. 
Upper panel: Normalized Fe 
K-edge XANES spectra of 
lipid free HMP (full line), 
lipid bound HMP (dashed 
line) and met-myoglobin 
(dotted line). Lower panel: 
Fourier transforms of the 
lipid free HMP (full line), 
lipid bound HMP (dashed 
line), and met-myoglobin 
(dotted line) EXAFS 
experimental spectra 
calculated in the range k= 
3.2-10.0 Å-1 using a Hanning 
window. 
 3.0 Å. Interestingly, the ferric, ligand free, HMP displays similar structural features within the 
iron first coordination shell with the CG carbon atom of LeuE11 at 3.4 Å distance from the 
iron atom. Thus, in ferrous lipid bound and ferric lipid free flavohemoglobins, the iron atom 
preserves a pentacoordinate stereochemistry and establishes no bonding interactions at the 
distal site.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2.4. Spectroscopic properties of  the mutant GluH23-Val 
The UV-vis absorption spectra of a mutant in which the glutamate 135 involved in an 
hydrogen bond with the proximal histidine (see above) is substituted by the apolar valine, is 
superimposable to the spectra of the native HMP. The mutant overespressed in E. coli is 
purified in the lipid bound form, which is stable even after the hydroxyl apatite 
chromatography step.  
Further investigations in the far infrared region show that the charge transfer band at 
760 nm (band III), typical of five coordinate high-spin ferrous heme (Chavez et al. 1990), is 
centred at 758 nm in HMP and shifted at 762  nm (Fig. 13) in the mutant. 
 
                  
 
 
 
Fig. 12 Heme iron 
coordination geometry in 
flavohemoglobins. 
The crystal structure of the 
active site of ferric, lipid free 
Escherichia coli 
flavohemoglobin (PDB 
code:1GVH; panel A) is 
compared with the structure 
of the ferrous 
cyclopropanpalmitoleic 
bound Alcaligenes eutrophus 
flavohemoglobin (PDB 
code:1CQX; panel C). The 
hypothetical structure of 
ferric, linoleic acid bound 
HMP is shown in panel B. 
The atoms belonging to the 
cluster used in EXAFS and 
XANES data analysis are 
shown as spheres. 
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Fig. 13 Far infrared spectra of  native HMP and HMP GluH23-Val. 
Spectra in the far infrared region of dithionite reduced native HMP (full line) and of HMP GluH23-Val (dotted 
line). Band III at 760 nm is shift at 762 nm in the mutant. 
 
 
 
3.3.3 Lipid binding kinetics 
HMP was shown to interact with bacterial lipid membranes and to be able to bind 
specifically phospholipids and fatty acids within the heme pocket. As previously mentioned, 
lipid binding is associated with spectroscopic  transitions in the EXAFS, resonance Raman 
and UV-vis. A fully reversible spectral transition is observed upon mixing the purified protein 
with total bacteria lipid extracts, but also with simple UFA and CFA free acids (see Fig. 14).  
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Subsequent titrations, carried out in buffers containing 20% v/v ethanol, pointed out that UFA 
and CFA bind to HMP with an extremely high affinity, even when the protein is pretreated 
with saturated fatty acids and/or saturated phospholipids. In order to strengthen the correlation 
Fig. 14 Spectral changes in the UV-Vis 
absorption region accompanying lipid 
binding to ferric E. coli
flavohemoglobin and kinetics of lipid 
release. 
A stoichiometric titration of lipid free, 
ferric HMP (12 µM heme) with an 
ethanol solution of oleic acid (3 µM per 
each addition) is shown in panel A. 
Panel B reports the kinetics of linoleic 
(?), oleic (?) and cyclopropan-
palmitoleic (?) acid release from HMP 
as obtained in competition essays with 
hydroxyalkoxypropyl-Dextrane. The 
continuous line represent the 
monoexponential fit to the linoleic acid 
data obtained by imposing the total 
absorbance change (at t=0) to the 
calculated value (k = 5±2.2×10-2 s-1). All 
experiments were carried out in 50 mM 
phosphate buffer at pH 7.0 in the 
presence of 20 % v/v ethanol at 20 °C. 
 between fatty acids binding and observed spectral signal and to estimate a value for the 
apparent affinity constant, a set of ligand combination kinetics were carried out by rapid 
mixing experiments. In these measurements, ferric HMP (in 20% ethanol) was mixed with 
increasing concentrations of palmitoleic, cyclopropanpalmitoleic and linoleic acid under 
pseudofirst order conditions. The time courses of linoleic acid binding to HMP as a function 
of wavelength and lipid concentration are reported in Fig. 15. The time courses were collected 
into a data matrix and processed by a Singular Value Decomposition (SVD) analysis in order 
to single out possible spectral intermediates. However, the procedure did not allow for an 
unequivocal deconvolution of the data set and eventually served to remove noise from the 
observed time courses. Fitting the (SVD) averaged time courses to single exponentials 
resulted in slightly biased time courses thus indicating that a more complex process than 
simple second order binding underlines the lipid binding process to HMP. Fatty acid 
concentrations higher than 0.1 mM could not be obtained due to solubility problems and thus, 
a full pseudo first order plot could not be produced. The apparent second order rate constant 
obtained from the fitting of the data of Fig. 15 C is around 2×106 M-1 s-1 (see also legend of 
Fig. 15). Palmitoleic and cyclopropanpalmitoleic acids displayed time courses 6-7 fold faster 
than linoleic acid and their kinetic parameters could not be estimated with certainty. A rough 
estimate of the lipid release rate was obtained by competition essays of lipid bound HMP with 
hydroxyalkoxypropyl-dextrane. The results obtained, shown in Fig. 14 B, indicate that 
palmitoleic and cyclopropanpalmitoleic acids are rapidly released from HMP (k > 0.1 s-1, 
assuming first order release). In contrast, linoleic acid dissociates with an apparent rate of 
5×10-2 s-1 thereby fixing the apparent affinity constant to a value of  about 4×107 M-1 (in the 
presence of 20 % ethanol). 
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Fig. 15 Kinetics of linoleic acid 
combination to ferric E. coli
flavohemoglobin. 
Panel A shows the static (continuous line) 
and kinetic (?) difference spectra in the 
Soret region of linoleic acid bound ferric 
HMP minus lipid free ferric HMP. Time 
courses, as obtained in rapid mixing 
experiments at two selected wavelengths, 
are shown in panel B. The kinetics records 
obtained at all wavelengths were collected 
into a data matrix and averaged by 
standard procedures (see Experimental 
Procedure). The averaged traces are shown 
in panel C together with single exponential 
fitting curves (continuous lines) and 
residuals. Apparent pseudo first order rates 
were 105 and 31 s-1, respectively. 
Experimental conditions were: protein 
concentration (after mixing), 5 µM; 
linoleic acid concentrations (after mixing), 
5×10-5 M (?) and 2.5×10-5 M (?); 0.1 M 
phosphate buffer, pH 7.0 containing 20 % 
ethanol and 20 °C. 
 3.4 HEME-LIGAND BINDING PROPERTIES OF HMP 
In order to compare the reactivity of the heme domain to that of other vertebrate and 
invertebrate Hbs, HMP reactivity has been analysed towards the typical ligands, that are 
imidazole for the ferric heme iron and CO and O2 for the ferrous heme iron. 
 
3.4.1 Heme-iron ligand binding properties of ferric HMP 
In the present investigation, the imidazole binding properties have been studied in 
detail since this ligand displays binding and release kinetics (see below) that are fast enough 
to allow for accurate equilibrium titrations even at very low (< 10-5 M) ligand concentrations. 
Titration experiments of ferric HMP with imidazole yielded different results when performed 
with lipid free or UFA, CFA or TLE saturated protein. Titration profiles of lipid bound HMP 
were fitted to the simple, one binding site, reaction Scheme I (Fig. 16). Imidazole equilibrium 
binding curves of lipid free HMP were fitted to the reaction Scheme II.  
 
                                  
 
Fig. 16 Reaction schemes for ligand binding to ferric E. coli flavohemoglobin. 
Ferric HMP has been inferred to possess a heme iron ligand binding site (-P) and a non heme binding site (P∼). 
Both sites are involved in the recognition of lipid (UFA or CFA) substrates ( ⎣ ⎦ ). The interaction of the lipid 
with the heme site is weak and can be diplaced by heme iron ligands (x), as depicted in Scheme I. Complete 
removal of the bound lipid renders the non-heme site available for ligand interaction as outlined in Scheme II. 
Ligand binding to the heme iron and is accompanied by a fast ligand exchange (k3 and k-3) between the heme and 
the non-heme binding sites. Full saturation of both sites implies a conformational transition from P to P* species.  
 
 
The presence of two ligand binding sites in Scheme II may appear paradoxical in a 
monomeric hemoprotein. Nevertheless, the presence of a single difference spectrum upon 
ligand binding (see Fig. 17) together with the strongly biphasic titration profile (Fig. 18) 
suggest an unusual mechanism of ligand saturation. The binding polinomial obtained from 
Scheme II is: 
 
Y = _[x- P∼] + [- P∼ x] + [x- P*∼ x]2 =      _K1 x + K2x + K4K1 x2__  ;         eq. (1 
  2 Ctot                                          2 {1+ K1 x + K2x + K4K1 x2} 
 
 Where x-P∼ represents the protein with heme bound imidazole, -P∼x is the protein 
with imidazole bound in the non-heme site and x-P*∼x is the doubly ligated species in which 
both the heme and non-heme site are occupied by the imidazole ligand. It is important to point 
out that the biphasic imidazole titration profiles cannot be corrected for the contribution of 
species spectrally different from that of unliganded and fully liganded derivatives. In other 
words, all spectra obtained within the imidazole titration experiments are accounted for a 
linear combination of the unliganded derivative and of the fully ligated adduct. The observed 
biphasic titration profiles can be fully described in terms of the Scheme II of Fig. 16 under the 
 assumption that imidazole binding to the non-heme site is spectroscopically silent. Hence the 
species -P∼x does not contribute to the observed signal and the species x-P*∼x yields the 
same spectral contribution as x-P∼ and the observed signal was fitted to a modified binding 
polynomial: 
 
Yobs = _[x- P∼] + [x- P*∼ x]2 =    ___K1 x + K4K1 x2____  ;                              eq. (2 
          Ctot                       1+ K1 x + K2x + K4K1 x2 
  
440400360320
1
0,8
0,6
0,4
0,2
0
A
bs
or
ba
nc
e
680640600560520480
0,24
0,2
0,16
0,12
0,08
0,04
0
x4
Wavelength (nm)  
 
Fig. 17 Spectrophotometric titration of ferric Escherichia coli flavohemoglobin with imidazole. 
Spectral changes accompanying the titration of the ferric protein with imidazole are shown in the visible (right) 
and Soret (left) regions. The spectrum of the unliganded derivative is rendered as a solid line whereas the dashed 
line pertains to the imidazole saturated spectrum. 
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Fig. 18 Ligand binding isotherms of ferric E. coli flavohemoglobin and horse Mb with imidazole. 
Titration experiments were carried out with imidazole on the lipid free HMP (O) and on HMP saturated with 
palmitoleic (    ), cyclopropan-palmitoleic (∆) and total E. coli lipid extracts (∇) in 0.1 M phosphate buffer at 
pH 7.0 and 20 °C. Control experiments have been also carried out on horse Mb in the presence (?) and in the 
absence (?) of TLE. Continuous lines represent fitting curves obtained by minimizing the experimental data to 
the schemes I and II (see Fig. 16 and Table I). The apparent equilibrium constant for imidazole binding to the 
protein saturated with palmitoleic, cyclopropan-palmitoleic and total E. coli lipid extracts were 1.8±0.5, 2.5±0.7 
and 3.6±0.2×103 M-1 respectively. 
 
 
 
As shown in Fig. 18, a simple single site titration profile is observed in the case of 
UFA (or CFA and TLE) saturated protein whereas lipid free protein displays a strongly 
biphasic behaviour characterized by a high affinity site (C½ around 1×10-5 M) and a low 
 affinity one (C½ around 1×10-3 M). The overall affinity of lipid saturated protein for 
imidazole is drastically decreased with respect to the high affinity site in the lipid free protein 
and is centred around 3×103 M-1. Fitting the equilibrium data with the binding polynomial 
given in eq. 2 yielded a complete set of thermodynamic constants whose values are reported 
in Table I. Such a minimal reaction scheme imposes severe constraints on the values of the 
equilibrium constants. In particular, the value of K3 appears to be frozen around unity as it 
determines the amplitudes of the two phases and thus the flexus in the titration profile. As a 
consequence,  K1 ≈ K2 and K4 ≈ K5 thus implying that the intrinsic affinity of the ligand 
molecule for the heme site and  for the non-heme site is very similar. In Fig. 18, control 
experiment performed on horse Mb are also shown. These data indicate that the imidazole 
titration profile of the protein is unaffected by the presence of TLE (ten molar excess of lipids 
with respect to the protein). 
 The kinetic behaviour of imidazole binding to HMP has been thoroughly analyzed in 
rapid mixing experiments. Imidazole binding kinetics of lipid bound (TLE) HMP is accounted 
for a simple second order process with a rate constant of 8×104 M-1s-1 (see Fig. 19, panel B). 
The rate of imidazole release calculated from the ratio between the second order rate and the 
equilibrium constants (3.6×103 M-1) is 22 s-1 whereas the same constant obtained from the 
pseudo first order plot (intercept with the Y axis) is around 6 s-1. The origin of such a 
discrepancy has not been understood. Imidazole combination reaction of lipid free HMP (Fig. 
19, panels A and B) also proceeded as an apparent single second order process under ligand 
concentration range that covered full saturation of the high affinity site and partial saturation 
of the low affinity site. The measured apparent combination rate was 4-5 faster than in lipid 
bound HMP yielding a value of 4×105 M-1s-1, as estimated from the pseudofirst order plot of 
Fig.19 panel B. The rate of imidazole release in the pseudofirst order plot of Fig. 19 B seems 
to converge to about the same value as in the lipid bound protein. Obviously, it cannot be 
compared with the value(s) calculated from the equilibrium constants and the second order 
rate constant. Thus, the whole set of imidazole binding time courses, measured on the lipid 
free protein, have also been fitted explicitly to Scheme II by imposing the value of the 
equilibrium constants obtained from the fitting of the titration data. The values of the rate 
constants obtained from the global fitting procedure are given in Table I. Cyanide 
combination kinetics was also measured in both lipid free and lipid bound HMP (data not 
shown). Time courses were characterized by a second order rate constant of 1.2×102 M-1 s-1 
indicating that cyanide binding kinetics is insensitive to the presence of the bound lipid. 
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Fig. 19 Imidazole combination kinetics to ferric E. coli flavohemoglobin. 
Panel A: imidazole combination time courses to ferric, lipid free HMP. Imidazole concentrations are reported in 
the abscissa of panel B. Continuous lines are the result of a global fitting procedure to Scheme II. The rate 
constants obtained are listed in TableI. 
 
Panel B: Apparent pseudo first order rates of the time courses reported in panel A as a function of imidazole 
concentration. Continuous lines represent linear fits to the data and yield apparent second order rate constants of 
4.1±0.1×105 M-1 s-1 for imidazole binding to the lipid free protein and of 8.5±0.2×104 M-1 s-1 for imidazole 
binding to HMP complexed with palmitoleic (  ), ciclopropan palmitoleic (∆) and TLE (total E. coli lipid 
extracts) (∇), respectively. Experiments were carried out in 0.1 M phosphate buffer, pH 7.0 and 20 °C. Protein 
concentration was 3-4 µM (after mixing). 
 
 
    Equilibrium constants                Rate constants  (s-1) 
 
K1          2.0±0.15×105 M-1                                    k1   22 
K2          2.2±0.25×105 M-1                         k2   0.3  
K3          1.1                                                k3    > 1000  
K4       6.6±0.3×103 M-1                           k4   0.05  
K5          6.0×103 M-1                                  k5   4                                         
  
 
Table I: Summary of thermodynamic and kinetic parameters for imidazole binding to ferric, lipid free, E. coli 
flavohemoglobin. 
 The equilibrium constants for imidazole binding to HMP were obtained by fitting the data of Fig. 17 to 
the binding polynomial relative to the reaction Scheme II (eq. 2). The rate constants were obtained according to 
the global fitting procedure of the data shown in Fig. 18, panel A to the reaction Scheme II (Fig. 16). In the data 
fitting of the rate constants, the equilibrium constants K1 to K5 were fixed and the first order rates of ligand 
release were allowed to float. Thus, the combination rate constants (k1’, k2’, k4’ and k5’) can be obtained from the 
equilibrium constants and the dissociation rate constants. The values of the ligand release constants are devoid of 
standard deviations as they are the result of a global fitting procedure. K2 and K4 values are automatically 
determined according to Scheme II. 
 
 
 
3.4.2 Heme-iron ligand binding properties of ferrous HMP 
 The ligand binding kinetic properties of the ferrous protein have been investigated by 
measuring the second order binding rates of CO and the first order kinetics of oxygen release 
on both the lipid free protein and on HMP saturated with different lipids or fatty acids. Lipid 
free HMP yielded biphasic second order CO binding kinetics whose rates and amplitudes (k1 
= 1.8×107 M-1s-1 (68 %) and k2 = 1.2×106 M-1s-1 (32%)) were almost superimposable to those 
obtained by Gardner et al. (2000). In contrast, experiments carried out on the protein saturated 
with TLE yielded perfectly monophasic CO ligand rebinding time courses after photolysis 
with a second order rate of  5.1×106 M-1s-1 (Fig. 20). In Fig. 20, the time course of CO 
rebinding after photolysis are shown in semilogarithmic plots. The absorbance decreases at 
434 nm are the results of three linear records obtained in the nanosecond to  millisecond time 
regime. In both lipid free and lipid saturated protein, no geminate recombination processes 
were detected as demonstrated by the flatness of the nanosecond time recording. CO release 
kinetics were not measured due to the difficulty in obtaining unbiased time courses with the 
NO displacement method in the presence of  a concomitant NO reduction (to N2O) reaction.   
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Fig. 20 Kinetics of CO binding to ferrous E. coli flavohemoglobin. 
Time courses of CO recombination after photolysis of TLE treated HMP as a function of CO concentration. The 
experiment has been carried out in 0.1 M phosphate buffer at pH 7.0 containing 250 µM NADH and 1 mM 
EDTA at 20 °C. Continuous lines represent monoexponential fits to the experimental points that yield a second 
order rate constant of 5.1±1.1×106 M-1s-1. The points in each data set (12000 points merged from three different 
acquisitions in the nanosecond, microsecond and millisecond time regime) have been logarithmically sampled. 
 
 
The kinetics of oxygen release, as monitored in oxygen pulse experiments (Fig. 21), 
are likewise biphasic in lipid free HMP with first order rates (koff) of 2.2 s-1 (44%) and 0.11 s-1 
(56%), respectively. In contrast, oxygen release from the TLE saturated protein are accounted 
for by a single exponential decay (koff = 0.16 s-1 at 20 °C). The behaviour of O2 release 
kinetics in HMP saturated with palmitoleic and cyclopropan-palmitoleic acid is intermediate 
between the lipid free and TLE saturated HMP in that the amplitude of the fast phase is 
decreased but not abolished. Direct oxygen binding kinetics have not been reported. Laser 
photolysis experiments on the oxygenated derivative are in fact severely biased by the NADH 
driven oxygen consumption occurring during the experiments thus requiring a more complex 
flow-flash measurements.   
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Fig. 21 Kinetics of oxygen release 
in ferrous E. coli flavohemoglobin. 
Time courses of oxygen release 
from TLE treated and lipid free 
HMP (panels A and B, respectively) 
have been obtained in oxygen pulse 
experiments (see Materials and 
Methods). Data in panel A have 
been fitted to a single exponential 
decay with an apparent rate of 
0.16±0.01 s-1. The kinetic record in 
panel B has been fitted to two 
exponentials characterized by 
apparent first order rates of  2.2±0.2 
s-1 (44%) and 0.11±0.03 s-1 (56%), 
respectively. The experiments have 
been carried out in 0.2 M phosphate 
buffer at pH 7.0 containing 25 mM 
sodium dithionite (after mixing) at 
20 °C.  
 3.4.3 Ligand binding properties of the mutant GluH23-Val 
In order to value the effect of the hydrogen bonding network involving the proximal 
histidine, oxygen release and carbon monoxide binding were measured on a HMP mutant in 
which GluH23 is substituted by valine.  
Interestingly, the affinity of the mutant for the phospholipid was increased with 
respect to the native protein such that the bound lipid could not be removed without 
denaturing the protein. Thus, ligand binding experiments have been carried out on the lipid 
bound derivative only. The oxygen release monitored in the oxygen pulse experiment shows a 
single exponential decay at 436 nm with a  koff = 24 s-1 at 20 °C (Fig. 22), that is two order of 
magnitude higher than that observed for the native protein. 
 The CO binding, instead, is apparently unaffected by the mutation and is comparable 
with the data obtained for lipid bound HMP. 
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Fig. 22 Kinetics of oxygen release in HMP Glu H23-Val. 
The time course of oxygen release has been only measured for the lipid bound protein as the affinity for this 
ligand is higher in the mutant than in the native protein. Removing the phospholipids is not feasible without 
destroying the protein. The kinetic is monophasic and shows a koff of 24 s-1 at 20°C and in the presence of 0.2 M 
phosphate buffer at pH 7.0 containing 25 mM sodium dithionite. 
 
 
 
3.5 ENZYMATIC ACTIVITY 
  The observed specificity for UFA and CFA binding within the active site of HMP 
strongly suggested a possible enzymatic activity towards these fatty acids. In particular, it was 
postulated that HMP might be endowed with a peroxidase or p450-like activity towards 
unsaturated phospholipid substrates possibly yielding oxygenated adducts on the double bond. 
Mono/dioxygenation and/or hydroxylation reactions were screened on several UFAs and 
CFAs as well as on aromatic hydrocarbons (benzene, toluene, naphthalene), and linear and 
cyclic alkenes (1-dodecene, 6-dodecene, cyclohexene, cyclooctene) by means of mass 
spectrometric analysis. The putative substrates were incubated in the presence of NADH, 
oxygen and variable amounts of protein. In spite of the high affinity for both oxygen and 
UFAs or CFAs and of the possibly favourable stereochemistry for oxygen addition to the acyl 
chain, no modifications of the fatty acid were detected under the experimental conditions used 
(i.e. pH 7.0, 20 °C and NADH as a reductant, see Table II).  
 
 
  
Lipid type                                                UV-Vis  spectral changes      ESI mass 
MW(g×mol-1) 
 
L-α dipalmitoyl phosphatidyl choline  −                                                                                                      
L-α dipalmitoyl phosphatidyl ethanolamine                  − 
L-α dipalmitoyl phosphatidyc acid  −  
palmitic acid    − 
stearic acid    − 
oleic acid     +    282 (282.5)* 
palmitoleic acid    +    254 (254.4) 
linoleic acid    +    278 (278.2) 
cis vaccenic acid    +    282 (282.5) 
9,10 methylen palmitoleic   +    265 (265.2) 
aromatic hydrocarbons   − 
(benzene, toluene, naftalene)   
linear and cyclic alkenes   − 
(1 dodecene, 6 dodecene, cyclohexene, cyclooctene) 
 
* Number in parenthesis indicate the calculated monoisotopic molecular weigth. 
 
 
Table II: Phospholipids and fatty acids binding to E. coli flavohemoglobin as screened by UV-Vis spectroscopy 
and ESI mass spectrometry.  
 
 
 
HMP is instead able to reduce oxygen in the presence of NADH producing H2O2. This 
reaction could be due to an uncoupled cycle which happens in absence of the substrate. It has 
been observed in cytochrome p450 that the electron equivalents that are not utilized to oxidize 
substrate are liberated from intermediate steps of the reaction cycle in the form of hydrogen 
peroxide (Loida et al. 1993). Nevertheless, no substrate modification was observed in HMP in 
the presence of the putative lipid substrate. In contrast, HMP was able to efficiently reduce 
hydrogen peroxide to water at the expenses of NADH reducing equivalents and under low 
oxygen content. This activity differs from the classical catalase activity (H2O2 
disproportionation to yield water and molecular oxygen) in that entails hydrogen peroxide 
reduction to water without oxygen production. This enzymatic activity has been formerly 
defined as peroxide-reductase activity and is typical of a class of enzymes identified as 
peroxiredoxins (Nishiyama et al. 2001, Takeda et al. 2004). In turn, the peroxiredoxin family 
comprises enzymes that are also capable of reducing alkyl hydroperoxides, the alkyl 
hydroperoxide reductases (Hillas et al. 2000, Gaber et al. 2001, Fisher et al. 1999, Seaver et 
al. 2001). Thus, the peroxide and alkyl hydroperoxide reductase activity of HMP was 
investigated further.    
Ferrous HMP has been demonstrated to posses a genuine alkyl hydroperoxide 
reductase activity in anaerobiosis, thus suggesting that HMP itself and possibly other member 
of the haemoglobin-like protein family are involved in the reduction of lipid membrane 
hydroperoxides. 
The hydroperoxide reductase activity of HMP was screened by using H2O2, tert-butyl 
hydroperoxide, cumyl hydroperoxide and linoleic acid hydroperoxide as substrates. The 
reaction products, analyzed by HPLC, GC or ESI mass spectrometry revealed transformation 
of the alkyl hydroperoxide species into their corresponding alcohols. A complete, quantitative 
analysis of the reaction products carried out for cumyl hydroperoxide is shown in Fig. 23.  
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Fig. 23 HPLC elution profiles of the reaction products obtained from the reaction of Escherichia coli 
flavohemoglobin and cumyl hydroperoxide. 
HPLC elution profiles of the reaction products obtained from the reaction of Escherichia coli flavohemoglobin 
and cumyl hydroperoxide. 
Panel A represents the elution profile (at 256 nm) of a reaction blank obtained from ethyl acetate extraction of a 
solution containing NADH (5 mM) and cumyl hydroperoxide (2 mM) in 0.1 M phosphate buffer and pH 7.0 
containing 1 mM EDTA (reaction carried out under N2 atmosphere, 1 h incubation at 20 °C). Panel B represents 
the elution profile obtained from the same reaction mixture in the presence of 10 µM HMP. The peaks are 
assigned as follows: 42.1 min, cumyl hydroperoxide; 36.9 min (A) or 36.7 min (B), cumyl alcohol; 28.7 min, 
acetophenone; 15.1 min, benzyl alcohol (internal standard). Acetophenone is present as a contaminant in the 
stock solution (3%) and is recovered in a similar amount in both reaction mixtures of panels A and B. Note that 
the molar absorptivity of acetophenone at 256 nm is 30 fold higher than that of cumyl alcohol. 
 
The ethyl acetate extracts obtained from the reaction mixture in the absence (blank) and in the 
presence of HMP, respectively, were analyzed by HPLC. Elution profiles are shown in panel 
A (blank) and Panel B. Benzyl alcohol (peak at 15.1 min) was used as an internal standard to 
quantify the reaction products. The elution profile of the blank in panel A demonstrates that 
stock solutions of cumyl hydroperoxide (peak at 42.1 min, 89 %) contained both 
acetophenone (peak at 28.7 min, 3% in) and cumyl alcohol (peak at 36.7 min, 8%) as 
contaminants. Data shown in panel B indicate a complete transformation of cumyl 
hydroperoxide into cumyl alcohol (peak 36.7 min) whereas the peak at 28.7 min reflects the 
small amount of acetophenone (whose molar absorptivity at 256 nm is about 30 fold higher 
with respect to that of cumyl alcohol) already present in the blank. Accordingly, GC mass 
data, performed in order to take into account the possible formation of  other volatile reaction 
products, revealed full conversion of cumyl hydroperoxide into cumyl alcohol in the reaction 
mixture (data not shown). 
 ESI mass spectrometric data (Fig. 24) revealed a similar trend in the case of linoleic 
acid hydroperoxide. Mass spectra of the ethyl acetate extracts of the blank solutions (in which 
either protein or NADH were absent) yielded a major peak at 311 a.m.u.  (corresponding to 
the molecular weight of linoleic acid hydroperoxide anion) whereas the dominant feature was 
at 295 a.m.u. (-16 a.m.u. with respect to the 311 peak) in the reaction mixture containing both 
protein and NADH. Spurious peaks at 334 and 317 a.m.u. (+22 with respect to 311 and 295 
a.m.u., respectively, attributed to Na+ ion adducts) are apparent in the blank and in the 
complete reaction mixture, respectively.  
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Fig. 24 ESI-MS spectra of the reaction products obtained from the reaction of Escherichia coli 
flavohemoglobin and linoleic acid hydroperoxide. 
The spectrum of a reaction blank obtained from an ethyl acetate extraction of a solution containing NADH (0.5 
mM) and linoleic acid hydroperoxide (140 µM) is shown in panel A. The major peak at 311 a.m.u. corresponds 
to linoleic hydroperoxide anion. Panel B represents the spectrum obtained from the same reaction mixture in the 
presence of  2 µM HMP. The major peak at 295 a.m.u. corresponds to linoleic alcohol. Experiments were carried 
out in 0.1 M phosphate buffer and pH 7.0 containing 1 mM EDTA (reaction carried out under N2 atmosphere, 15 
min incubation at 20 °C). 
 
Reaction kinetics were monitored on the different substrates by means of UV-visible 
absorption spectroscopy in both spectrophotometric experiments at low protein concentrations 
(0.2-1 µM) and in stopped flow, rapid kinetic measurements at higher protein concentrations 
(4-6 µM). HMP activities, determined upon increasing amounts of alkyl hydroperoxides or 
H2O2 to degassed HMP solutions in the presence of excess NADH (250 µM) are depicted in 
Fig. 25. Double reciprocal plots of Fig. 25 are the result of several separate experiments 
carried out on different protein preparations.  
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Fig. 25 Double reciprocal plots of 
Escherichia coli flavohemoglobin 
alkylhydroperoxide reductase 
activity versus cumyl 
hydroperoxide concentrations. 
The activities were measured under 
N2 atmosphere in the presence of 
0.2-1 µM protein, 250 
µΜ ΝΑ∆Η ιν 0.1 Μ πηοσπηατε β
υφφερ ατ πΗ 7.0. Τηε στραιγητ λι
νε ρεπρεσεντσ α λινεαρ φιττινγ τ
ο τηε εξπεριµενταλ δατα. Ιν πανε
λ Β, ΧΟ ινηιβιτιον οφ τηε αλκψλ 
ηψδροπεροξιδε ρεδυχτασε αχτιϖ
ιτψ ϖερσυσ χυµψλ ηψδροπεροξι
δε ισ σηοων. Τηε δασηεδ λινε χο
ρρεσπονδσ το τηε λινεαρ φιτ ρεπ
ορτεδ ιν πανελ Α. Τηε χοντινυου
σ λινεσ ρεπρεσεντ τηε λινεαρ φιτ
σ το τηε δατα οβταινεδ ιν τηε σα
  ξ    
 Data linearization and fitting yielded the set of steady state kinetic parameters reported in 
Table III. The highest activity was observed for cumyl and linoleic acid hydroperoxides 
whereas reduction of tert-butyl hydroperoxide and hydrogen peroxide was two- and three-fold 
slower, respectively (Table III). It should be pointed out that reaction with linoleic acid 
hydroperoxide is strongly solvent dependent. Data obtained in the presence of 0.1% Triton X–
100 were fully reproducible and displayed nearly zeroth order kinetics. In contrast, 
experiments carried out in 20 % ethanol/water mixture (in which substrate is soluble up to 2-3 
mM concentration at 25 °C) exhibited a slightly slower rate and displayed nearly exponential 
time courses. 
 
 
hydroperoxide                   Km (µM)                 Vmax (nmol/min/mg)* 
 
H2O2                                     260±28                           789±102 
Tert-Butyl                              76±15                          1125±135 
Cumyl                                    55±15                          2564±155 
Linoleic                                  26±14a                        1876±188a 
             115±33b                         872±215b 
 
a 0.1% Triton X-100 
b 20% etanol/water mixture 
* For comparison with data from other authors, activities can be redimensioned “per mol” 
using the molecular mass of 43,000 g mol−1 for HMP. 
 
Table III: Escherichia coli flavohemoglobin steady state kinetic constants for hydroperoxide substrates. Data 
were obtained in 0.1 M phosphate buffer pH 7.0 containing 250 µM NADH, 1mM EDTA and 25 °C. a) 0.1% 
Triton X-100; b) 20% ethanol/water mixture.  
 
 
Carbon monoxide inhibition of the hydroperoxide reduction reaction was also determined for 
cumyl hydroperoxide. The data reported in Fig. 25 B indicate a clear competitive inhibition 
mechanism by CO with an apparent Ki of about 0.2 µM (calculated from the apparent Kmapp 
values according to a simple Michelis Menten formalism). 
 Rapid kinetic experiments, carried out by mixing degassed HMP solutions (8 µM) in 
the presence of excess NADH (320 µM) with cumyl hydroperoxide (1 mM) solutions are 
depicted in Fig. 26 A. The kinetic spectral profiles were characterized by a fast decay at 340 
nm (t1/2 = 3 s) due to NADH oxidation while HMP remains in its fully reduced (ferrous 
heme, reduced flavin), deoxygenated derivative. Upon depletion of NADH reducing 
equivalents (5-6 s), HMP undergoes complete oxidation (ferric heme, oxidized flavin). A 
similar trend is observed with linoleic acid hydroperoxide whereas the formation of a 
spectroscopically distinct contribution characterized by a an absorption peak at 420 nm was 
noticed under stationary state conditions in the reaction with tert-butyl hydroperoxide (data 
not shown). The species characterized by the 420 nm peak was the dominant feature in the 
reaction of ferrous HMP with hydrogen peroxide (Fig. 26 B). Analysis of the time dependent 
spectral profiles of Fig. 26 allowed the identification of the absorption spectra relative to each 
species (see also Fig. 27). The spectral profile 3 obtained from the data of Fig. 26, was thus 
attributed to an oxo-ferryl heme iron adduct by analogy with the spectra of typical 
Compounds II of peroxidases and must be distinguished from the ferrous heme iron dioxygen 
adduct (profile 4). The oxo-ferryl adduct was relatively stable (seconds to minutes) under 
reducing conditions (250 µM NADH) and 50-250 µM hydrogen peroxide concentrations 
whereas it rapidly decayed to a mixture of ferric heme and unidentified heme degradation 
 products in the presence of H2O2 in larger excess (> 2 mM). In order to confirm the oxo-ferryl 
spectrum assignment, the following set of controls were carried out: i) the species obtained in 
the presence of H2O2 and NADH was mixed with CO saturated solutions (1 mM) in a double 
mixing experiment and no spectral changes were observed; ii) the same compound could not 
be reduced with sodium dithionite. 
 
Fig. 26 UV-Visible absorption spectral changes accompanying hydroperoxide reductase activity in 
Escherichia coli flavohemoglobin. 
Spectra were collected with a diode array device after mixing a solution of ferrous HMP (8 µM) containing 250 
µM NADH with a solution containing 1 mM cumyl hydroperoxide (A) or 1 mM H2O2 (B). The measurement has 
been carried out in 0.1 M phosphate buffer at pH 7.0 containing 1 mM EDTA and 20 °C. Solutions were 
degassed and kept under nitrogen before use. 
 
                                  
 
Fig. 27 UV-Visible absorption spectra of Escherichia coli flavohemoglobin intermediates in its reaction 
with alkyl hydroperoxides. 
 The spectrum of ferric HMP (1) has been taken at the end (10 s) of the reaction of HMP with cumyl 
hydroperoxide. NADH reduced, deoxygenated HMP spectrum (2) was collected before mixing with cumyl 
hydroperoxide. The spectrum of the HMP Compound II intermediate (3), obtained as a transient species from the 
experiment carried out with H2O2 (see Fig. 3, Panel B), can be compared with the spectrum of fully reduced, 
dioxygen HMP adduct (4). Spectra 2, 3 and 4 have been corrected by subtracting the contribution of NADH. All 
spectra have been taken at pH 7.0 in 0.1 M phosphate buffer. 
 This data suggest that HMP is capable of recognizing the alkyl hydroperoxide moiety 
because of the highly hydrophobic distal heme pocket, and in the case of peroxidized 
phospholipids containing unsaturated fatty acids, HMP is able to adjust the hydrocarbon chain 
kink in correspondence of the cis double bound above the heme iron. The binding of the 
hydroperoxide to the ferrous heme iron occurs with the concomitant two electron reduction 
and the cleavage of the dioxygen bond and consequent formation of a peroxidase-like 
Compound II and an alkyl alcohol (see Fig. 28).  
 
 
 
Fig. 28 Probable reaction scheme catalyzed by HMP.  
The ferrous protein is able to bind the hydroperoxy-phospholipid by recognizing the double bond. The 
hydroperoxide is reduced to alcohol and the heme-iron is oxidized to Compaund II. Reduction of the oxo-ferryl 
compound to water and ferric heme with concomitant flavin oxidation and release of the hydroxy-phospholipid 
to the membrane may be hypothesized. R1 and R2 represent two not yet identified species (protein’s aminoacids 
or water molecules) that are able to exchange protons.  
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 4. DISCUSSION 
 
The results obtained in the present thesis have brought out a complete picture of 
Escherichia coli flavohemoglobin structure and of its functional properties in vitro. The 
solution of the tridimensional structure, the analysis of the ligand binding properties, the 
identification of a putative physiological function and the comparative analysis of the 
sequences of the flavohemoglobin family have been carried out and will be discussed also in 
the light of other most recent publications in the field. 
 
4.1 THE TRIDIMENSIONAL STRUCTURE OF HMP 
The structure of flavohemoglobins represents a paradigmatic example among 
multidomain proteins in which two modules with different functions are fused together in 
order to create a protein endowed with entirely novel functional properties. The first 
tridimensional structure of a flavohemoglobin, obtained in 1995 by Ermler et al. (Alcaligenes 
eutrophus flavohemoglobin, FHP), had shown that flavohemoglobins are made of a C-
terminal NAD- FAD-binding domain, member of the FdR-like family, and an N-terminal 
globin domain (Fig. 1). Surprisingly, inspection of the structure of the globin domain active 
site in FHP revealed that the distal heme pocket was occupied by a phospholipid molecule. 
The presence of this bulky ligand was apparently unrelated to possible functional roles of 
FHP and rendered the understanding of the geometry of the active site particularly difficult. 
On this basis, the first part of the present work was devoted to the crystallization of the highly 
homologous Escherichia coli flavohemoglobin in its lipid free form. The overall structure of 
ferric unliganded HMP, obtained at 1.6 Å resolution, brings about analogies and differences 
with the structure of the globin domain of the flavohemoglobin from Alcaligenes eutrophus 
and of the highly similar single chain hemoglobin from Vitreoscilla sp (Tarricone et al. 1997, 
Bolognesi et al. 1999).  
The globin domain is structurally analogous to vertebrate myoglobins. It consists of 
eight alpha helices (A, B, C, …H) that enclose the heme cofactor within a hydrophobic pocket 
in which the heme iron is coordinated by His F8 on the proximal side. Inspection of the distal 
heme pocket in HMP (ferric unliganded derivative) has brought out a very different picture 
from that initially proposed on the basis of the tridimensional structures of FHP (ferrous 
derivative in the presence of a phospholipid) and VHB (ferric cyano-met, aquo-met and 
azido-met) derivatives. In fact, in HMP, the distal side is occupied by the Leu E11 isopropyl 
side chain that shields the heme iron from the residues in the topological positions predicted 
to interact with heme iron bound ligands, namely Tyr B10 and Glu E7, and stabilizes a 
pentacoordinate ferric iron species. This unique architecture, completed by the canonical Phe 
CD1 residue, provides a very hydrophobic shell on the top of the iron atom such that 
displacement of the Leu E11 side chain is necessary in order to allow ligand binding to the 
iron atom. Thus, Leu E11, can be considered as the genuine distal residue in 
flavohemoglobins in the same manner as His E7 is the canonical distal residue in most 
vertebrate hemoglobins. In this frawework, it is of interest to comment on the differences 
observed between the ferric unliganded HMP and the ferrous, phospholipid bound FHP. 
The main differences between these two proteins are the E helix positioning within the 
globin domain and a rotation of the NAD-binding module. These structural changes must be 
attributed to the presence of the phospholipid molecule in FHP. Thus, the comparison 
between ligand free HMP and ligand bound FHP is strongly suggestive of a ligand linked 
conformational change that entails the rotation of the Leu E11 isopropyl side chain 
(accompanying the movement of the E helix) towards the edge of the heme in order to allow 
the Tyr B10 phenol hydroxyl interact with the iron bound ligand. This interpretation explains 
the experimental evidence obtained by resonance Raman and FTIR spectroscopy, for the 
participation of a Tyr hydroxyl (either direct or most likely mediated by a water molecule) to 
the distal coordination of bound CO in the ferrous protein (Mukai et al. 2001, Bonamore et al. 
 2001). In fact, previous Raman and FTIR measurement showed that ferrous CO-bound HMP 
is characterized by the presence of two conformers in which the diatomic ligand is either 
stabilized by a hydrogen-bonding interaction to the Tyr B10 (closed conformation) or free of 
distal constrains (open conformation). The present structure pertaining to a ligand free 
derivative offers a different view in which the Tyr B10 residue lies far from the diatomic 
ligand contact region and is shielded by the isopropyl side chain of Leu E11. Thus, the 
positioning of Leu E11 indicates that this residue not only gates the accommodation of the 
incoming ligand but also hinders the access of the Tyr B10 phenol hydroxyl to the distal 
ligand contact area. In other words, a ligand linked motion entails the displacement of the Leu 
E11 side chain (open conformation) followed by the approaching of the Tyr B10 hydroxyl to 
the iron-bound ligand to form a hydrogen bonding interaction (closed conformation). 
The proximal heme environment in flavohemoglobins is also peculiar and differs from 
that observed in vertebrate hemoglobins and myoglobins in that the proximal histidine is 
involved in a hydrogen bond network with Glu135 and Tyr95 (Fig. 3). These observations, 
coupled to resonance Raman data (Mukai et al. 2001), indicate that HMP as well as FHP and 
in general bacterial hemoglobins bear more resemblance to peroxidases rather than 
hemoglobins. In fact the Tyr B10-Gln E7 pair may play a similar role as the distal His-Arg 
pair in peroxidases and the proximal histidine is involved in a strong hydrogen bond 
interaction with a carboxyl group (Asp235 in cytochrome c peroxidase, Glu135 in HMP). 
Regarding the FAD-binding domain, the structural overlay of the isoalloxazine 
binding motif in lipid free HMP versus lipid bound FHP reveals a structural rearrangement of 
the C-terminal segment that face the NAD-binding side of the flavin ring. This structural 
change has been interpreted as a specific signature of a phospholipid induced conformational 
transition in FHP that also entails a movement of the whole NAD binding module with 
respect to the FAD-binding domain (Fig. 5).  
The clarification of the structural properties of HMP with respect to FHP and the 
understanding of the architecture of the active sites of these proteins allowed a rational 
evaluation of the structure based alignments of the whole flavohemoglobin family. Sequence 
alignments were carried out on Gram negative bacteria (Enterobacteriaceae, Vibrionaceae, 
Pseudomonaceae, Rhizobiaceae) as well as on Gram positive bacteria 
(Bacillaceae and Micrococcaceae) and even unicellular eukaryotes. The 
flavohemoglobin family is formed by a very homogeneous group of proteins that share highly 
conserved active sites in both the heme and flavin binding domains. A multiple sequence 
alignment of about 50 proteins from different bacterial and eukaryotic microorganisms shows 
that the residues surrounding the heme cofactor in HMP, namely Tyr B10, Glu E7, Lue E11, 
His H8, Glu135, Tyr95 are conserved in all analyzed flavohemoglobins (Fig. 7A). The 
residues involved in the creation of a hydrophobic moiety for the phospholipid 
accommodation in FHP and that ones contouring the flavin binding cavity are also conserved 
(Fig. 7B). 
The high similarity among all flavohemoglobins obviously suggests common 
functional properties. In particular, the presence of the tightly bound phospholipid within the 
heme pocket of A. eutrophus flavohemoglobin suggested the participation of bacterial 
hemoglobins to some sort of lipid membrane transport and/or processing (Ollesch et al. 1999). 
More recently, the single chain bacterial hemoglobin from Vitreoscilla sp. (VHB) and the 
truncated hemoglobin from Mycobacterium tubercolosis (HbO) have been reported to be 
preferentially located in contact with the bacterial inner membrane in vivo and to be capable 
of reversible binding to liposome obtained from bacterial lipid extracts in vitro (Ramandeep et 
al. 2001, Pathania et al. 2002). HMP itself has also been reported to interact with membrane 
phospholipids although with no apparent specificity for any kind of lipid molecule (Ollesch et 
al. 1999).  The lipid binding properties of HMP have thus been investigated in detail. 
 
 
 4.2 LIGAND BINDING PROPERTIES 
 
4.2.1 Lipid binding properties 
The presence of a phospholipid within the heme pocket of the Alcaligenes eutrophus 
flavohemoglobin prompted the investigation of the lipid binding properties in HMP in order 
to determine whether lipid binding is a general property of flavohemoglobins and whether it 
may have a physiological significance. In simple UV-visible absorption experiments it was 
demonstrated that HMP is capable of interacting with bacterial lipid membranes and is also 
able to recognize specifically UFA and CFA. These data challenge previous reports on 
Vitreoscilla hemoglobin, Alcaligenes eutrophus flavohemoglobin and HMP itself that 
envisaged an unspecific interaction with membrane phospholipids (Ollesch et al. 1999, 
Ramandeep et al. 2001). Most interestingly, binding of UFA or CFA to HMP gives rise to a 
clear spectroscopic change in the visible spectrum of the ferric heme (Fig. 9). In fact, the 
absorption spectrum of the unliganded derivative corresponds to a typical pentacoordinated 
heme adduct in which the proximal histidine is the fifth ligand, as demonstrated by the peak at 
645 nm and the broad Soret band, characterized by a low molar absorptivity and centered 
around 403 nm (Boffi et al. 1999). In contrast, the spectrum of the UFA (or CFA) saturated 
species displays a sharp peak at 407 nm and a shallower one at 625 nm and is very similar to 
that of high spin adducts observed in many other hemoglobins and myoglobins in the 
presence of weak ligands such as fluoride (Antonini et al. 1971, Giangiacomo et al. 2001). 
Thus, the spectral profile of lipid bound HMP is diagnostic of the formation of a 
hexacoordinated species in which the sixth coordination position is occupied by a component 
of the fatty acid chain. We propose that the double bound or cyclopropane ring recognition by 
the flavohemoglobin involves a weak but direct bonding interaction to the heme iron atom. 
Nevertheless, inspection of the crystal structure of the ferrous, lipid bound, A. Eutropus FHP 
(1.75 Å resolution) indicates that the iron-nearest carbon atom (CA of the cyclopropane ring, 
see Fig. 12) in ferrous, lipid bound, FHP is at 3.5 Å distance from the metal. Such distance 
preclude any bonding interaction between the iron atom and the distal ligand in that no orbital 
overlap can be predicted to occur involving the dz2 ferrous or ferric iron orbital at a distance 
higher than 3.0 Å. Interestingly, the ferric, ligand free, HMP (1.6 Å resolution) displays 
similar structural features within the iron first coordination shell with the CG carbon atom of 
LeuE11 at 3.4 Å distance from the iron atom. Thus, in ferrous lipid bound and ferric lipid free 
flavohemoglobins, the iron atom preserves a pentacoordinate stereochemistry and establishes 
no bonding interactions at the distal site. Our results on the ferric lipid bound HMP complete 
the picture but also offer a different view. In agreement with the crystallographic data, optical 
absorption (both in solution and in the crystals) and resonance Raman spectroscopy points out 
unambiguously that the lipid free, ferric derivative is a pentacoordinate species and the 
LeuE11 residue does not establish a bonding interaction with the ferric iron. In contrast, the 
formation of a hexacoordinate derivative is clearly demonstrated upon lipid binding to the 
ferric HMP protein by the low frequency shift of the core size marker bands (Choi et al. 1982, 
Boffi et al. 1999). The appearance of a hexacoordinate high spin species is accompanied by an 
unusually intense band at 319 cm-1, attributed to a γ6 heme out of plane vibrational mode (Fig. 
10). The conversion from a pentacoordinate to a hexacoordinate species is consistent with the 
formation of an axial bonding interaction between the ferric heme iron and the lipid (linoleic 
acid or TLE) moiety. Our analysis pointed out that lipid induced spectral changes, attributed 
to lipid binding, are specific for UFA and CFA free fatty acids as well as for negatively 
charged phospholipids esterified with a UFA or a CFA molecule. UFA or CFA methyl esters 
are not recognized by the protein binding site. No binding has been detected with saturated 
phosphatidil ethanolamine and phosphatidyl glycerol derivatives (the most abundant 
phospholipids within E. coli membrane) nor with saturated fatty acids and simple linear or 
cyclic hydrocarbons containing cis double bonds. Thus, on the basis of the structural data of 
Ollesch et al. (1999), an explicit model for UFA or CFA binding to HMP has been proposed 
 in which the negatively charged part of the lipid moiety is hosted in an anion binding cavity 
located next to the heme pocket and the cyclopropane ring or the double bond are directly 
coordinated to the iron atom. In order to single out the nature of such an unusual iron-ligand 
bonding interaction EXAFS measurements have been carried out in parallel on the ligand free 
and lipid bound protein. The picture that emerges from these studies is both enlightening and 
intriguing. Direct inspection of the FT spectra (Fig. 11, panel B) points out that differences 
between the lipid free and lipid bound ferric protein are manifest within a shell of 2-4 Å from 
the iron atom. In particular, when comparing the FT spectra of ligand free and lipid bound 
HMP, an additional shoulder 2.3 Å accompanied by an increase in intensity of the peak at 3.5 
Å can be observed in the latter spectrum. This feature is assigned to an axial contribution in 
the sixth coordination position in lipid bound HMP. Quantitative analysis of the EXAFS data 
indicates that a bonding interaction does occur between the ferric heme iron and a couple of 
atoms located at 2.7 Å from the metal. 
HMP Glu135-Val is also able to bind phospholipid with an even higher affinity than 
the native protein. In fact, the lipid is retained by the protein after the hydroxylapatite 
purification step, as well after a column of hydroxyalkoxypropyl-destrane, that removes 
phospholipids from native HMP.  
Complete kinetic and thermodynamic parameters for fatty acid binding to ferric HMP 
have been obtained for linoleic acid only in the presence of ethanol (20 %) as a co-solvent. 
The binding constant, estimated from ligand binding and release data is about 4×107 M-1 (or 
kd = 25 nM), a figure that is similar to that of true type fatty acid binding proteins (Balendiran 
et al. 2000).  
The absence of binding to pure DPPC liposomes (DPPC is not synthesized in bacteria) 
indicates that HMP can actually recognize the polar heads of naturally occurring 
phospholipids of E. coli membrane and does not interact with the hydrophobic core of the 
bilayer. The identification of an anion binding site (fully compatible with a phosphate binding 
site) in a protein loop above the heme pocket allows one to hypothesize a recognition of the 
membrane through an interaction of the loop with the phosphate moiety of the phospolipid 
molecule. Thus, HMP most likely works at the interface between the cytosol and the bacterial 
inner membrane and is permanently saturated with a phospholipid esterified with either an 
UFA or a CFA molecule. 
 
4.2.2 Heme-iron ligand binding properties of ferric HMP 
 The broad, biphasic equilibrium titration profile for ligand binding to ferric, lipid free 
HMP and VHB (Bolognesi et al. 1999) represents a puzzling thermodynamic behaviour that 
had not been understood as yet. In a previous investigation, ligand binding to VHB was 
interpreted as an anticooperative behaviour due to the apparently dimeric nature of the protein 
(Bolognesi et al. 1999). Subsequently, the presence of a dimeric species in VHB has been 
challenged in an ultracentrifugation investigation thus leaving the biphasic equilibrium ligand 
binding properties unexplained (Giangiacomo et al. 2001).   
 A complete reaction scheme (Fig. 16) that takes into account the observed ligand 
binding profiles has been unravelled on the basis of a set of  equilibrium and kinetic 
measurements carried out on both lipid bound and lipid free HMP. According to Scheme I, 
the lipid is weakly coordinated to the heme iron and is strongly bound to the non-heme site. 
Imidazole binding to the heme iron occurs upon displacement (not rate limiting, at least in the 
case of imidazole) of the weak iron-lipid bond and is entirely accounted for by a typical single 
site ligand binding process. The non-heme site must possess a very high affinity for the polar 
lipid head such that it cannot be displaced by heme iron ligands. 
 In the lipid free protein, the set of imidazole binding kinetics and equilibrium 
measurements suggested that the ligand might be able to occupy a protein site or cavity next 
to the heme that allows for rapid exchange with the heme iron. It is envisaged that the 
incoming ligand is coordinated by the heme iron (k1’>k2’) and then rapidly partitioned (k3’ ≈  
 k3 >1000 s-1) between the metal and the spectroscopically silent non-heme site (Scheme II). 
This picture is in agreement with the presence of the two sites previously postulated for UFA 
recognition, i.e. the heme iron site that is capable of coordinating the acyl chain double bond 
(or cyclopropane ring) and a polar cavity that is necessary for harbouring the polar head of the 
lipid. Thus, heme iron ligands might be hosted by the polar site in competition with the heme 
iron in the lipid free HMP. 
 The main question that arises from the proposed mechanism concerns the nature of the 
non-heme binding site and its unusual high affinity for the typical ferric heme iron ligands. 
Attempts to identify the non-heme site by direct X-ray diffraction measurements has failed in 
that ferric HMP crystals appear to grow only at pH 5.0 and thus under unfavourable 
conditions for cyanide or imidazole binding (both ligands are protonated). Moreover, HMP 
crystals were also unstable upon increase in the pH values of the mother solution. 
Nevertheless, all X-ray diffraction maps thus obtained (including the deposited structure 
1gvh, Brookhaven Protein Data Bank) do show electron density in a loop region above the 
heme pocket comprising residues Asp44-Arg54. The electron density in the loop region has 
been assigned to a chloride ion although the geometry of the site shares some similarity to 
typical phosphate coordination regions. In particular, two Arg residues (Arg49 and Arg54) 
appear to provide a strong positive charge density that allows for coordination of anionic 
species. It may be envisaged that the loop region, that is endowed with high flexibility, is 
involved in the coordination of the fatty acid carboxyl and is also able to bind typical heme 
iron ligands. It is also worth recalling that conformational heterogeneity and hence high 
flexibility has been postulated to explain the lack of a definite diffraction pattern of the loop 
region above the heme pocket in ferric ligand free and ligand bound VHB (Tarricone et al. 
1997, Bolognesi et al. 1999).  
 
4.2.3 Heme-iron ligand binding properties of  ferrous HMP 
 The effect of the bound lipid on the ferrous protein, although undetectable in the 
absorption spectra, manifests itself in both CO binding and oxygen release kinetics. It should 
be mentioned that the description of the CO and oxygen kinetic behaviour is not complete in 
that no reliable data could be obtained on the oxygen binding process and on the CO release 
kinetics within the present experimental set up. Thus, the model described for imidazole 
binding in Scheme II cannot be directly carried over the ferrous protein.  Laser photolysis 
experiments on CO bound HMP revealed very fast and biphasic CO rebinding time courses in 
the lipid free protein, in agreement with the findings of Gardner and co-workers, (Gardner et 
al. 2000). In contrast, 10 fold slower and monophasic ligand rebinding kinetics are obtained in 
the TLE saturated HMP (see Fig. 20). Oxygen release kinetics are also affected by the 
presence of a bound lipid. Lipid free protein is characterized by a strongly biphasic oxygen 
release kinetics whose rates and amplitudes are almost superimposable to those obatained on 
lipid free Vitreoscilla Hb (Bolognesi et al. 1999). In contrast, a monoexponential (0.16 s-1) 
oxygen release process is observed in the lipid saturated protein (Fig. 21).  
These experimental observations offer further indications on the interplay between 
lipid binding and heme iron ligand binding in HMP. The absence of a heme spectroscopic 
signal in ferrous, lipid bound, HMP is not surprising in that, as observed for most 
hemoglobins, weak ligands of the ferric heme (e.g. fluoride, nitrite, azide) are rapidly released 
upon iron reduction (Antonini et al. 1971). Nevertheless, given the significant effect on the 
kinetic parameters of CO and oxygen binding/release, it must be envisaged that the lipid acyl 
chain is present in the heme pocket thus impairing CO binding and favouring oxygen release 
processes. Alternatively, the fatty acid might be bound to the non heme site and stabilize a 
single conformation that reacts slowly with CO and is capable of faster oxygen release (P* 
conformation of Scheme II). In turn, the lipid free protein must be endowed with a 
conformational equilibrium between two species to explain the heterogeneity observed in CO 
binding and oxygen release. These hypothesis (that are not mutually exclusive) may be 
 reconciled with previous findings based on resonance Raman (Mukai et al. 2001) and infrared 
spectroscopic (Bonamore et al. 2001) investigations (carried out on the lipid free protein) that 
envisaged the presence of two distinct conformers in the CO ligated species. The presence of 
two separate CO stretching frequencies had been attributed to the presence of an “open” and a 
“closed” conformers (Bonamore et al. 2001). In the “closed“ conformer, it has been suggested 
that iron bound CO is stabilized by the Tyr B10 phenol hydroxyl whereas it is apparently free 
of constraint in the “open” conformation (Bonamore et al. 2001). Although the reaction 
Scheme II cannot be easily carried over the ferrous protein, it is tempting to speculate that the 
“closed” conformation may correspond to the x-P∼ species whereas the “open” conformation 
might be represented by the doubly x-P*∼(x) derivative. Interestingly, Scheme II predicts that 
if the ligand binding rate (k1’) exceeds the rate of ligand exchange between the heme and the 
non-heme site (k3’), a biphasic ligand binding kinetics should be observed, as indeed observed 
for CO binding to the lipid free protein (Gardner et al. 2000).  
The kinetics of oxygen release and CO binding have been also investigated for the 
mutant Glu135- Val in its unique lipid bound derivative. While CO combination is almost 
superimposable to that obtained for the native protein,  the oxygen release is about two orders 
of magnitude higher (Fig. 22). It is consistent with the loss of the anionic nature of the 
proximal histidine, which is no more involved in the hydrogen bond network. In fact, the 
imidazolate property of His F8 becomes lower in Glu135-Val HMP and the electronic density 
of the heme iron higher. So the affinity for the oxygen decreases in the mutant as the koff 
decreases  and the kon that we measured for the CO remains constant. 
 
 
4.3 ENZYMATIC ACTIVITY 
On the basis of the ligand binding data, we searched for a possible enzymatic activity 
towards fatty acids or phospholipids. Mono/dioxygenation and/or hydroxylation reactions 
were screened on several UFAs and CFAs by means of ESI mass spectrometric analysis of 
fatty acid solutions incubated in the presence of NADH, oxygen and variable amounts of 
protein (see Table II). The reaction products have been also analysed by GC/MS of the related 
methyl esthers. In spite of the high affinity for both oxygen and UFAs or CFAs and of the 
possibly favourable stereochemistry for oxygen addition to the acyl chain, no modifications of 
the fatty acid were detected under the experimental conditions used (i.e. pH 7.0, 20 °C and 
NADH as a reductant). Moreover, addition of hydrogen peroxide to the HMP/substrate 
mixture did not resulted in any modification of the added lipid. In contrast, it was noticed that 
NADH consumption was increased in the presence of hydrogen peroxide with a rate that was 
inversely proportional to the oxygen concentration of the buffer. This activity is typical of 
peroxiredoxins, a family of proteins involved in the physiological response to oxidative stress 
in microorganisms. Thus, the peroxiredoxin activity of HMP was tested also on a large set of 
organic alkyl hydroperoxides.  
The results obtained indicated clearly that HMP is endowed with a novel enzymatic 
activity that might be described in the framework of the oxidative stress response of the 
bacterial cell. In fact, it has been demonstrated that HMP is capable of a very efficient alkyl 
hydroperoxide reductase activity towards a set of synthetic substrates, namely tert-butyl, 
cumyl and linoleic acid hydroperoxides. Interestingly, the hydroperoxide reductase activity is 
higher towards cumyl, tert-butyl and linoleic acid hydroperoxides than towards H2O2 thus 
indicating a preference for highly hydrophobic substrates (Table III). This finding must be 
analyzed in parallel with recent investigations in which HMP was also shown to interact with 
bacterial lipid membranes and to be able to bind specifically phospholipids and/or fatty acids 
within the heme pocket. Taken together, these observations pave the way to a functional role 
for HMP and possibly other members of the bacterial hemoglobin family: HMP is involved in 
the repair of peroxidized membrane phospholipids thus reducing hydroperoxides into their 
corresponding alcohols.  
 The alkyl hydroperoxide reductase activity is widespread among diverse bacterial 
species and is thought to represent a major functional response of the cell to oxidative stress. 
E. coli itself posses a protein annotated as alkyl hydroperoxide reductase (AhpC), a NADH-
dependent peroxidase that rapidly reduces organic hydroperoxides. AhpC belongs to the 
peroxiredoxin family (Prxs), that includes thiol-specific antioxidant proteins. Their catalytic 
cycle is the following: the peroxidatic cysteine attacks the peroxide substrate and is oxidized 
to a cysteine sulfenic acid; it follows the peroxide decomposition and the exit of the 
corresponding alcohol. In the second step of the peroxidase reaction the peroxidatic cysteine 
sulfenic acid is attacked by another cysteine residue within the protein or located at the C-
terminus of another subunit in multimeric enzymes. In the last step the so generated disulfide 
bond is reduced by specific disulfide oxidoreductase (AhpF in E. coli) (Wood et al. 2003). 
Prxs probably overlap to some extent with the better known glutathione peroxidases and 
catalase, although it has been suggested that their moderate catalytic efficiencies (∼105 M-1s-1) 
compared with those of glutathione peroxidases (∼108 M-1s-1) and catalases (∼106 M-1s-1) 
make their importance as peroxidase questionable (Hofmann et al. 2002).  
AhpC seems also to be involved in H2O2 scavenging (Seaver et al. 2001), although E. 
coli possesses two catalases: HPI and HPII, encoded by katG and katE genes respectively. 
However, AhpC scavenges low concentration of H2O2 very efficiently, while HPI and HPII 
might act at higher concentration of H2O2, against which AhpC is ineffective. So AhpCF 
peroxiredoxin complex plays a pivotal role in removing hydrogen peroxide in E. coli cells 
under stationary phase conditions (in virtue of a lower Km value with respect to catalases), 
whereas it is less efficient as a lipid hydroperoxide scavenger.  
 The conversion of cumyl hydroperoxide to cumyl alcohol (currently used as a standard 
for comparing the alkyl hydroperoxide reductase activity among different enzymes) catalysed 
by HMP occurs at a rate (2564 nmol/min/mg) that is at least two orders of magnitude higher 
than that measured for the E. coli AhpCF complex under similar experimental conditions 
(Nishiyama et al. 2001) and about 2 fold higher than that measured for the most efficient 
Amphibacillus xylanus peroxiredoxin reductase under saturating condition of AhpC (Niimura 
et al. 1995). Such a high activity corresponds to a turnover number (mole of substrate per 
mole of protein) of 110 min-1 (see Table III). CO inhibition experiments (Fig. 25, panel B) 
demonstrate that the activity is heme-linked and is not a spurious effect due to the presence of 
the highly reactive flavin prosthetic group within the protein. The residual activity observed in 
HMP in the presence of CO is in fact fully compatible with a competitive inhibition 
mechanism in which substrate binding is limited kinetically by the rate of CO release from the 
heme iron. 
 Simple inspection of the time dependent absorption spectra offers several interesting 
insights into the mechanism of the alkyl hydroperoxide reductase activity. Analysis of the 
spectroscopic data of Figs. 26 and 27, together with previous experimental observations on 
lipid binding to HMP, permits an unequivocal elucidation of the early steps in the mechanism 
of alkyl hydroperoxide reduction and establishes differences and analogies with classical 
heme based peroxidase enzymes. Heme peroxidase catalyzes the following global reaction: 
2AH2 + ROOH → 2AH· + ROH + H2O. The native ferric enzyme reacts with the oxidizing 
substrate (H2O2 or ROOH) to yield compound I, a reactive intermediate with higher formal 
oxidation state (+5 compared with +3 for the resting enzyme). Then compound I can oxidize a 
range of reducing substrates by a mechanism involving two sequential single electron steps. 
That leads the generation of compound II (oxidation state +4) that is reduced to resting 
enzyme (oxidation state +3) by a second molecule of reducing substrate. In the presence of 
H2O2 in excess another intermediate can be identified, that is compound III (oxygenate 
derivative with oxidation state +2). Oxygen bound to the ferrous heme in compound III is 
released as peroxide returning the resting enzyme.  
HMP is capable of recognizing the alkyl hydroperoxide moiety due to the highly 
hydrophobic distal heme pocket and, in the case of peroxidized phospholipids containing 
 unsaturated fatty acids, has been inferred to be able to adjust the hydrocarbon chain kink in 
correspondence of the cis double bond above the heme iron. Thereafter, binding of the 
hydroperoxide to the ferrous heme iron occurs with the concomitant two electron reduction 
and cleavage of the dioxygen bond and consequent formation of a peroxidase-like compound 
II and an alkyl alcohol. It is important to note that this first step does not imply electron 
transfer from the flavin to the heme iron but rather a direct two electrons iron oxidation. The 
fate of the ferryl-oxo compound thus generated is less obvious. Reduction of the ferryl-oxo 
compund to water and ferric heme with concomitant flavin oxidation and release of the 
hydroxylphospholipid to the membrane may be hypothesized. Most intriguingly, the active 
form of the protein, capable of binding a new molecule of substrate, is the ferrous derivative 
and not the ferric one. In fact, at variance with classical peroxidases, no alkyl hydroperoxide 
and/or H2O2 binding to the heme iron can be detected when the heme iron is in the ferric state. 
Consistently, ferric HMP is unable to perform monoxygenations typically catalyzed by 
peroxidases and/or cytochrome p450 on a broad variety of substrates (see Tab. II). 
At present, a direct, in vivo, determination of the HMP dependent alkyl hydroperoxide 
reductase activity still needs to be explored. Nevertheless, a number of experimental 
observations on HMP expression in response to oxidative stress conditions provide 
convincing evidence for a genuine physiological role of the protein in the repair of oxidative 
damage. In particular, it was observed that HMP expression, controlled by the FNR 
transcription factor, is enhanced under conditions of prolonged oxidative stress such as those 
imposed by administrating paraquat and other agents generating oxygen reactive species to 
the culture medium (Membrillo-Hernandez et al. 1999, Anjum et al. 1998). This finding is 
consistent with HMP being transcribed in a later phase after the oxidative pulse. In fact, 
whereas the fast response to oxidative stress is governed by enzymes that are directly under 
the control of the transcription factor OxyR (Nishiyama et al. 2001, Kheng et al. 2001), the 
late response to oxidative stress involves a web of interactions that ultimately lead to HMP 
transcription (Anjum et al. 1998). Thus, enzymes involved in hydrogen peroxide scavenging 
(AhpCF and KatG/E gene products) or DNA protection (Dps gene product) are rendered 
available as a first barrier against peroxidation whereas HMP and possibly other substrate 
specific enzymes may play a role in the repair of diverse peroxidized species. In this 
framework, the link between the reported NO induced (FNR mediated) expression of HMP 
(Cruz-Ramos et al. 2002) and oxidative stress may reflect another facet of the complex and 
intimately correlated responses of the bacterial cell to NO and oxygen reactive species. NO 
induction of enzymes involved in the oxidative stress response is in fact well documented 
(Ding et al. 2000) and explicit mechanisms that envisage an increase of the alkyl 
hydroperoxide reductase activity in the presence of NO have been proposed (Bryk et al. 
2000). In particular, nitroperoxide species, formed at diffusion limited rate by the reaction of 
NO with superoxide anion, is known to be a strong promoter of membrane lipid peroxidation 
(Hogg et al. 1999). Accordingly, NO induced HMP expression, under low oxygen tensions, 
might well allow a direct (FNR mediated) mechanism for lipid hydroperoxide reduction 
whereas peroxiredoxins actively scavenge nitroperoxide anions (Bryk et al. 2000).  
 On the basis of the considerations just presented, HMP and other bacterial 
hemoglobins would be key enzymes in maintaining the cell membrane integrity at the 
aerobic/anaerobic interface. Such a hypothesis also provides a plausible explanation for the 
reported high growth performance of E. coli overproducing bacterial hemoglobins under 
microaerobic environments (Bollinger et al. 2001). Nevertheless, other catalytic options must 
also be considered in further studies. In fact, lipid hydroperoxide reductase activity might be 
part of a specific reaction pathway that leads to the formation of lipid hydroperoxide derived 
active compounds whose functions are, as yet, to be established. It is worth mentioning that in 
chloroplasts, for instance, unsaturated fatty acid hydroperoxides are converted to signalling 
molecules by specific cytochrome p450-like proteins such as hydroperoxide lyase and allene 
oxidase (Baier et al. 1999). Unsaturated fatty acid processing by heme based cycloxygenase 
 enzymes is also at the basis of the eicosanoids pathway in eukaryotic cells. Intriguingly, 
cycloxygenases have been proposed to be activated by NO (or by nitroperoxide) in order to 
trigger the catalytic cycle. In the same way, bacterial hemoglobins might be involved in the 
(possibly NO driven) processing of phospholipids in the framework of a more complex 
physiological response. 
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